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Clearance of molecularly damaged and misfolded synaptic vesicle (SV) proteins is vital 
for the maintenance of healthy, functional synapses. However, this process poses significant 
trafficking challenges for neurons, as the majority of degradative organelles and machinery are 
localized in the somatodendritic compartment, far from SV pools in presynaptic terminals. Our 
previous work showed that SV protein degradation is mediated by the endosomal sorting 
complex required for transport (ESCRT) pathway in an activity-dependent manner. Moreover, 
we found that neuronal activity increased ESCRT protein recruitment to axons and SV pools, 
suggesting a novel mechanism for regulating the trafficking of this critical degradative 
machinery, whose localization and transport in neurons has been unexplored. Here, we 
characterize the axonal transport of ESCRT-0 proteins Hrs and STAM1, the first components of 
the ESCRT pathway, which are critical for initiating SV protein degradation. We find that Hrs- 
and STAM1-positive transport vesicles exhibit increased anterograde and bidirectional motility 
in response to neuronal activity, as well as frequent contact with SV pools. ESCRT-0 vesicles 
typically colocalize with early endosome marker Rab5, but their transport dynamics do not 
mirror those of the total Rab5 vesicle pool. Moreover, other ESCRT pathway components and 
effectors do not show activity-dependent changes to motility, indicating that neuronal firing 
specifically regulates the motility of the ESCRT-0+ subset of Rab5+ structures in axons. Finally, 
we identify kinesin-3 motor protein KIF13A as essential for the activity-dependent transport of 
ESCRT-0 vesicles as well as the degradation of SV membrane proteins. Altogether, these studies 
demonstrate a novel activity-dependent mechanism for mobilizing the axonal transport of a 
 
newly characterized endosomal subtype carrying ESCRT machinery. This activity-induced 
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Chapter 1: General Introduction 
 
Synaptic Health and Maintenance 
 
 
Synaptic Breakdown and Neurodegeneration 
 
Neurons are cells with a fundamentally communal function. They exist, in essence, to 
interact with each other, and the resulting interneuronal communications form the basis of 
mammalian life.  Synapses, the conduits through which neurons interact, are therefore essential 
to neuronal function, and synaptic health is fundamental to the health of a brain as a whole. 
Studies of neurodegenerative disease have shown that presynaptic dysfunction often precedes 
cell death (Gorman 2008; Chi, Chang, and Sang 2018). Moreover, ‘synaptopathy’ and synaptic 
dysfunction are endemic to all neurological diseases regardless of etiology, symptomology, 
mortality, or age of onset (Taoufik et al. 2020). It is therefore clear that long-term synaptic 
homeostasis, and the cellular pathways that maintain it, are vital to the prevention of neurological 
disease. 
 
Synaptic Protein Turnover 
 
Synaptic vesicles (SVs) are the fundamental units of neurotransmitter storage and release, 
and as such their efficient recycling is essential for neuronal communication. These processes 
depend upon maintaining the proper complement of functional SV membrane proteins, as the 
inability to clear nonfunctional or misfolded SV proteins can precipitate synaptic dysfunction 
and neurodegeneration (Bezprozvanny and Hiesinger 2013; Esposito, Ana Clara, and Verstreken 
2012; Hall et al. 2017). SV proteins begin to lose functionality and are taken out of the active 
pool as they age (Truckenbrodt et al. 2018), presumably due to an accumulation of molecular 
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damage that occurs over the lifetime of a protein. Previous work has shown that cytosolic 
synaptic proteins are degraded via the ubiquitin-proteasome system (UPS) and macroautophagy 
(Cohen and Ziv 2017), while membrane-associated synaptic proteins, including synaptic vesicle 
proteins, are degraded under basal conditions by the endolysosomal system (Sheehan et al. 2016; 
Uytterhoeven et al. 2011, 2017). Both the macroautophagy and endolysosomal degradative 
pathways are thus vital to synaptic health. 
 
Synaptic Autophagy  
 
*Note: A version of following section (every sub-heading under ‘Synaptic Autophagy’) has been 




Macroautophagy, hereafter referred to as ‘autophagy’, is one of the primary cellular 
degradative pathways. Although it has only recently become a focus of research in synaptic 
biology, emerging studies indicate that autophagy has essential functions at the synapse 
throughout an organism’s lifetime.  
 
Autophagy in Synapse Development 
 
Studies in genetic organisms indicate the importance of autophagy and autophagic 
machinery in early synaptic development. For instance, impairment of autophagy via the 
knockdown of ATG1, -2, -6, or -18 was found to reduce the number and size of presynaptic 
terminals at the neuromuscular junction (NMJ) in Drosophila melanogaster (Shen and Ganetzky 
2009). More recently, Stavoe and Colon-Ramos showed that autophagy is required cell-
autonomously for presynapse formation in AIY neurons of C. elegans (Stavoe et al. 2016). They 
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found that autophagosome biogenesis occurred at developing AIY presynaptic boutons. They 
then observed that 18 distinct components from every stage of the autophagy pathway – 
initiation (UNC-15, ATG-13), nucleation (ATG-9), elongation (LGG-1, LGG-3, ATG-3, ATG-
4), and retrieval (ATG-2, ATG-9, ATG-18)– were required for the clustering of synaptic vesicle 
(SV) proteins at nascent presynaptic sites during AIY neuron development (Stavoe et al. 2016). 
However, these components were not required for SV clustering in other C. elegans neuron 
types, suggesting a cell-specific role for autophagic machinery in presynaptic development. 
These findings highlight the importance of autophagy for synaptogenesis, and the need for future 
studies to clarify its roles in different cell types and organisms. 
In the mammalian brain, synapse formation is followed by a period of synapse 
refinement, and autophagy has been shown to play an important role in this process. Tang and 
colleagues found that autophagy is required for the developmental pruning of dendritic spines, 
and that this pruning is disrupted in individuals with autism spectrum disorder (ASD) (Tang et al. 
2014). Intriguingly, the authors found a statistically significant increase in phosphorylated 
mTOR (p-mTOR), the activated version of mTOR, in the brains of ASD patients compared to 
age-matched controls. Since the activation of mTOR inhibits autophagy, an increase in mTOR 
activity typically indicates a reduction of autophagy (Tang et al. 2014). Indeed, ASD patients 
exhibited significantly lower levels of LC3-II, a marker for autophagosomes, throughout 
childhood and adolescence. Moreover, Tang et al. observed that mTOR hyperactivation in mice 
led to ASD-like behaviors and spine pruning deficits in cortical projection neurons, indicating 
that autophagy is essential for synaptic pruning, and that defects in autophagy contribute to ASD 
phenotypes (Tang et al. 2014).  
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Overall, these studies show that autophagic machinery is vital for both synapse formation 
and pruning during development. However, many questions remain. For example, does the 
autophagic machinery regulate SV clustering via protein degradation or another mechanism? Are 
other aspects of synapse formation also regulated by this machinery? Most importantly, how are 
autophagy components temporally and spatially regulated to facilitate SV clustering in certain 
contexts, and synapse pruning or SV degradation in others? Answers to these questions will lead 
to a deeper understanding of how autophagy functions throughout neurodevelopment to facilitate 
synapse formation and elimination.  
 
Autophagic Cargo at the Synapse 
 
Mitochondria 
Mitochondria can become depolarized and dysfunctional following damage to 
mitochondrial DNA by reactive oxygen species (ROS) (Guo et al. 2013). The term ‘mitophagy’ 
was coined by Rodriguez-Enriquez and colleagues in 2006 to describe the selective autophagy of 
damaged or excessive mitochondria (Rodriguez-Enriquez et al. 2006). Since then, mitophagy has 
been shown to be essential for the removal of damaged mitochondria in all eukaryotic cell types, 
including neurons (Ding and Yin 2012; Tang et al. 2014). Mitochondria are critical sources of 
ATP at synapses, and several studies indicate that deficient mitophagy leads to synaptic 
dysfunction (Ebrahimi-Fakhari et al. 2016; Haddad et al. 2013). Recent studies implicate the 
Parkinson’s disease (PD)-related proteins PTEN-induced putative kinase (PINK1) and Parkin, an 
E3 ubiquitin ligase, as critical mediators of mitophagy in axons and presynaptic terminals of 
hippocampal neurons (Ashrafi et al. 2014).  These proteins were previously shown to work in 
concert to target mitochondria for degradation, as PINK1 localizes to the mitochondrial 
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membrane and upon phosphorylation recruits Parkin to damaged mitochondria (N. Matsuda et al. 
2010; Narendra et al. 2010; Vives-Bauza et al. 2010). Parkin in turn ubiquitinates mitochondrial 
membrane proteins to promote recruitment of the autophagic machinery (Mouton-Liger et al. 
2017; X. Wang et al. 2011). However, more recent studies call into question whether the 
PINK1/Parkin pathway is essential for triggering the removal of damaged mitochondria from 
axons and presynaptic boutons. For example, Sung and colleagues found that Parkin deficiency 
in Drosophila led to the accumulation of abnormal mitochondria in cell bodies, rather than in 
axons or presynaptic boutons as would be expected if PINK1/Parkin are required for initiating 
the clearance and retrograde transport of these organelles (Sung et al. 2016). Moreover, another 
study showed that the removal of stressed mitochondria from axons of hippocampal neurons 
required the retrograde motor protein syntaphilin but not Parkin (M. Y. Lin et al. 2017), 
suggesting a Parkin-independent mechanism for detecting mitochondrial dysfunction and 
mediating its retrograde transport prior to mitophagy. Additional evidence shows that basal 
mitophagy is unaffected in Pink1 or parkin null Drosophila, although these flies exhibit 
locomotor defects and dopaminergic neuron loss, demonstrating that PINK1 and Parkin are not 
essential for in vivo mitophagy, or that their function is cell-type specific (J. J. Lee et al. 2018). 
 
Synaptic Vesicles 
Autophagy has also been found to mediate the degradation of synaptic vesicles (SVs) in 
some circumstances. Notably, Hernandez and colleagues found that in dopaminergic neurons, 
stimulating autophagy with rapamycin decreased SV number and evoked-dopamine release, 
while blocking autophagy via ATG-7 knockout increased dopamine release (Hernandez et al. 
2012). These findings suggest that, at least in dopaminergic neurons, induction of autophagy can 
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stimulate SV degradation, while loss of this pathway leads to increased SV release and/or 
number. However, other studies in Drosophila and mammalian hippocampal neurons suggest 
that the endolysosomal degradative pathway mediates basal and activity-dependent turnover of 
SV proteins (Sheehan et al. 2016; Uytterhoeven et al. 2011, 2017). A synthesis of these studies 
suggests that although activation of autophagy can stimulate SV degradation and regulate 
neurotransmitter release under some conditions, autophagy may not be the primary mechanism 
of SV protein degradation. It is also worth noting that the autophagy and endolysosomal 
pathways are linked, as autophagosomes fuse with late endosomes prior to lysosomal 
degradation (Berg et al. 1998; Liou et al. 1997; Fader and Colombo 2008). Thus, it can be 
difficult to parse the roles of the autophagy and endolysosomal pathways in the degradation of 
specific cargoes, and in the case of synaptic vesicle degradation it is possible that the two 
pathways work synergistically. 
Regardless of the specific substrates, considerable evidence suggests that presynaptic 
autophagy is tightly regulated and, distinct from basal autophagy, activated only under certain 
conditions (Vijayan and Verstreken 2017). Indeed, several recent studies have begun to identify 
the molecular machinery that activates and inhibits autophagy in presynaptic terminals. Okerlund 
and colleagues report that the active zone cytomatrix proteins Bassoon and Piccolo are negative 
regulators of presynaptic autophagy in hippocampal neurons (Okerlund et al. 2018). Following 
up on previous findings that Bassoon/Piccolo double knockdown (DKD) triggered the 
progressive loss of SV pools by stimulating degradative pathways (Waites et al. 2013), the 
authors observed an accumulation of LC3-positive and autophagosome-like vesicles in 
presynaptic DKD boutons (Okerlund et al. 2018). They subsequently demonstrated that Piccolo 
and Bassoon regulate autophagy via their suppression of ATG-5, an E3 ubiquitin ligase-like 
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enzyme essential for coupling LC3 to the membrane of nascent autophagosomes. Both active 
zone proteins directly interact with ATG-5, and its knockdown rescues the increase in LC3-
positive structures and concurrent decrease in SV pools seen in DKD neurons (Okerlund et al. 
2018). These data indicate that Bassoon/Piccolo act to restrain presynaptic autophagy, and that 
dysregulated autophagy due to the loss of these proteins stimulates the degradation of SVs. 
However, it is not yet clear whether autophagy is specifically regulated by Bassoon/Piccolo or 
induced by a broader neuronal stress response following the loss of one or both of these critical 
synaptic structural determinants. More work is needed to clarify the roles of these proteins in 
regulating presynaptic autophagy and other degradative pathways (e.g. endolysosomal, ubiquitin-
proteasome), as well as the involvement of autophagy in presynaptic vesicle degradation under 
basal conditions.  
Additional insights about the molecular regulation of presynaptic autophagy come from 
two recent studies in the Verstreken lab (Soukup et al. 2016; Vanhauwaert et al. 2017). Soukup 
and colleagues showed that autophagic factors are recruited to presynaptic boutons by the 
endocytic protein EndophilinA (EndoA) following its phosphorylation by LRRK2, a Parkinson’s 
disease-related kinase (Soukup et al. 2016). Vanhauwaert et al. found that synaptojanin, a 
presynaptic lipid phosphatase also important for SV endocytosis, is similarly crucial for 
autophagy. In Drosophila synapses and neurites of iPSC-derived neurons with mutant 
synaptojanin, nascent autophagosomes accumulated Atg18a on their membranes and could not 
mature into functional autophagosomes (Vanhauwaert et al. 2017). Moreover, Parkinson’s 
disease-associated synaptojanin mutations caused dopaminergic neuron loss in Drosophila 
Vanhauwaert et al. 2017), linking the dysregulation of presynaptic autophagy to 
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neurodegenerative disease, and highlighting the importance of this process for nervous system 
health. 
 
Postsynaptic AMPA receptors 
Across the synaptic cleft, autophagy also mediates the degradation of postsynaptic cargo, 
including neurotransmitter receptors. Some of the first evidence for this came from Rowland and 
colleagues, who showed that GABAA receptors colocalize with autophagosome markers at the C. 
elegans motor neuron/body wall junction in the absence of neuronal activity, and that post-
synaptic GABAA activity is attenuated in an autophagy-dependent manner (Rowland et al. 2006). 
Interestingly, the authors also found that this autophagic degradation was selective, as GABAA 
but not acetylcholine receptors localized to autophagosomes (Rowland et al. 2006). Matsuda et 
al. subsequently observed that hippocampal and cerebellar AMPA receptors were mistargeted to 
axonal autophagosomes in the absence of the trafficking adaptor complex AP-4, instead of being 
delivered to the dendritic plasma membrane (S. Matsuda et al. 2008). Although this study did not 
demonstrate autophagy of AMPA receptors in dendrites, a later study reported more direct 
evidence of AMPA receptor degradation at synapses through the autophagy-lysosomal pathway. 
Specifically, Shehata and colleagues found that high potassium stimulation or chemical stimuli 
to induce long-term depression (LTD) briefly increased autophagosome numbers in dendritic 
shafts and spines, an effect that was partially NMDA receptor-dependent (Shehata et al. 2012). 
Moreover, the levels of AMPA receptor subunit GluA1 decreased following chemical LTD, and 
this degradation was partially mitigated by autophagy inhibitors. These results indicate that 
postsynaptic autophagy is regulated by neuronal activity, and at least partially responsible for the 
degradation of AMPA receptors following LTD (Shehata et al. 2012), suggesting a possible role 
 
 9 
for autophagy in synaptic plasticity mechanisms. However, given the preponderance of evidence 
demonstrating that AMPA receptors are degraded through the endolysosomal pathway (Ehlers 
2000; Zheng et al. 2015; Schwarz, Hall, and Patrick 2010) and ubiquitin proteasome system 
(UPS) (Ferreira et al. 2015; Goo, Scudder, and Patrick 2015), it will be important to clarify 
whether autophagy works in parallel with these other pathways, or is stimulated only during 
specific circumstances, e.g. induction of LTD. Despite many lingering questions, it is clear that 
autophagy mediates the degradation of important synaptic substrates (Figure 1), and that future 




Figure 1. Proposed regulators and cargo of synaptic autophagy. In the presynaptic terminal, 
autophagosome formation is promoted by EndophilinA (EndoA) following its phosphorylation by 
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LRRK2. Conversely, the presynaptic structural proteins Bassoon and Piccolo inhibit autophagic 
degradation of synaptic vesicles via negative regulation of ATG-5. Mitophagy is induced when PINK1 is 
phosphorylated and recruits Parkin to damaged mitochondria. Postsynaptically, AMPA receptors are 




Given the distinct molecular compositions and features of the juxtaposed pre- and 
postsynaptic compartments, one important unresolved question is whether pre and post-synaptic 
autophagosomes have unique characteristics and/or regulatory mechanisms. A recent study by 
Maday and colleagues supports this idea, as the authors find that autophagosomes originating in 
axons of hippocampal neurons exhibit distinct characteristics from those originating in the 
somatodendritic region (Maday and Holzbaur 2016). The former appear overwhelmingly 
‘mature,’ i.e. positive for the late endosome/lysosome marker LAMP1, once they enter the 
somatodendritic compartment following their retrograde axonal transport, while the latter are less 
mature and less mobile overall (Maday and Holzbaur 2016). These findings suggest that 
neuronal and/or synaptic compartmentalization creates molecularly distinct pools of 
autophagosomes that exhibit different dynamic behavior and functional properties. Additional 
work will be needed to determine whether these autophagosomes are indeed molecularly distinct 
and/or responsive to compartment-specific regulatory stimuli. 
 This possibility of distinct spatially and conditionally regulated autophagosomes 
dovetails with mounting evidence that there are multiple classes of LC3-positive structures. 
Although LC3 is considered a specific and reliable marker of autophagosomes, it is worth noting 
that LC3 was first identified in rat neurons as the light chain of microtubule-associated proteins 
MAP1a and MAP1b, components of the neuronal cytoskeleton (Mann and Hammarback 1994). 
Its role in autophagy was recognized only later by Kabeya and colleagues (Kabeya 2000). In 
keeping with the potentially versatile role of LC3, Kononenko et al. reported that a subset of 
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LC3-positive structures undergoing retrograde transport from presynaptic terminals exhibited 
colocalization with the endocytic adaptor AP-2 and with BDNF-activated TrkB receptors, which 
are traditionally found in signaling endosomes (Kononenko et al. 2017). One interpretation of 
these data is that presynaptic autophagosomes can merge with signaling endosomes, or that these 
retrograde cargoes are co-transported. Another possibility is that LC3 associates with multiple 
vesicle types, including autophagosomes, signaling endosomes, and potentially other structures.  
 
 
Figure 2. Diverse membrane structures observed at Bassoon/Piccolo DKD synapses. A) Electron 
micrograph of a presynaptic terminal expressing VAMP2-HRP to label synaptic vesicles (red arrow). 
‘M’ denotes mitochondria. B) Examples of structures found at DKD synapses, shown to have increased 
autophagy and LC3-positive vesicles. These structures include vacuoles (arrowheads), putative double-
membrane autophagosome (red arrow), multivesicular bodies (green arrows), as well as structures that 




Interestingly, it was observed by Waites, Okerlund, and colleagues that Bassoon/Piccolo DKD 
boutons, shown to be LC3-immunopositive, contained multiple heterogeneous membrane 
structures, most of which did not resemble classical autophagosomes (Waites et al. 2013; 
Okerlund et al. 2018) (Figure 2). It is also worth noting that the other mammalian Atg8 
homologs, namely GABARAP and GATE-16, likewise exhibit many functions at the synapse, 
some unrelated to autophagosome formation. GABARAP in particular has been shown to be 
involved in the trafficking of GABA-A receptors to the neuronal plasma membrane (Leil et al. 
2004), and has numerous binding partners that are involved in a diversity of dynamic processes 
underlying synapse formation, maintenance, and plasticity (Mohrlüder, Schwarten, and Willbold 
2009). Together, these studies indicate how much there still is to learn about protein trafficking 




ESCRT Pathway Components and Mechanics 
 
The endosomal sorting complex required for transport (ESCRT) pathway is required for 
the endolysosomal degradation of membrane proteins in eukaryotic cells. ESCRT machinery 
comprises a series of protein complexes termed ESCRT-0, I, II, III, and VPS4/Vta1, which 
together form an ancient system for membrane remodeling (Figure 3) (Hurley 2015). Each 
complex is conserved at least in part from yeast to mammals, and plays a role in the formation of 
multivesicular bodies, pre-degradative endosomal structures characterized by cargo-carrying 
intraluminal vesicles. The loss or dysfunction of almost every ESCRT component results in 
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endosomal dysfunction, usually the formation of class-E structures in yeast, or enlarged 
endosomes in mammalian cells (Schuh and Audhya 2014).  
 
Figure 3. The ESCRT Pathway. ESCRT Complexes ESCRT-0,I,II,III and Vps4/Vta1 (not shown) are 
recruited sequentially to the endosomal membrane to sequester ubiquitinated membrane protein cargo 
and insert it into intralumenal vesicles, ultimately creating a multivesicular body (MVB). 
 
 ESCRT-0 is the first component of the pathway and is necessary to cluster ubiquitinated 
cargo in the endosomal membrane as well as recruit later ESCRT complexes. Comprising two 
proteins, Hrs (Hepatocyte growth factor-regulated tyrosine kinase substrate; 777 amino acids) 
and STAM (Signal transducing adaptor molecule; 540 amino acids; isoforms STAM1 or 
STAM2) (Figure 4), ESCRT-0 is thought to exist as a 2:2 heterotetramer on the endosomal 
membrane (Mayers et al. 2011; Schuh and Audhya 2014). Hrs localizes to the endosome through 
interactions between its Fab1, YOTB/ZK632.12, Vac1, and EEA1 (FYVE) domain and 
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phosphoinositol-3-phosphate, and between its coiled-coil (CC) domain and the membrane 
(Raiborg et al. 2001). It binds ubiquitin with a 127 M affinity in vitro using a double-sided 
ubiquitin interacting motif (DUIM), and clusters ubiquitinated cargo on the endosomal 
membrane, localizing it to clathrin-rich domains via its C-terminal clathrin-binding (CB) domain 
(Schuh and Audhya 2014). Hrs and STAM interact at their CC domains. STAM also binds 
ubiquitin, albeit more weakly, with UIM and VHS domains (Bache, Raiborg, et al. 2003). 
Additionally, STAM has an SH3 domain that has been shown to interact with deubiquitinases 
(DUBs) (Schuh and Audhya 2014). ESCRT-0 thus recognizes and clusters ubiquitinated cargo 
into specific membrane microdomains that become the sites of intraluminal vesicle formation. It 
also recruits the next component in the pathway, the ESCRT-1 complex, via an interaction 
between the Hrs PxxP domain and the ubiquitin E2 variant (UEV) domain of ESCRT-1 protein 
TSG101 (Bache, Brech, et al. 2003; Schuh and Audhya 2014). 
 
Figure 4. Relevant domains of ESCRT-0 proteins Hrs and STAM. Abbreviations are as follows: 
Clathrin Binding (CB), Coiled-Coil (CC), Double-Sided Ubiquitin-Interacting Motif (DUIM), Fab-1, 
YGL023, Vps27, and EEA1 (FYVE), P= Proline, x= any amino acid (PxxP), Src homology-3 (SH3), 
Ubiquitin Interacting Motif (UIM), Vps27p, Hrs, and STAM (VHS). 
 
 ESCRT-I comprises four conserved proteins: TSG101 (390aa), Mvb12B, Vps37, and 
Vps28. Unlike ESCRT-0, ESCRT-I does not stably associate with the membrane and relies on its 
interaction with ESCRT-0 to target the endosomal membrane. The UEV domain of TSG101 
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weakly binds ubiquitin with ~510 M affinity (Bilodeau et al. 2003; Katzmann, Babst, and Emr 
2001). This interaction does not appear to be necessary for cargo sorting, but along with the 
ubiquitin-binding motif present in ESCRT-II, may represent a sort of outer failsafe for retaining 
ubquitinated cargo in the area (Schuh and Audhya 2014).  
 ESCRT-II similarly does not stably associate with endosomal membranes, but rather 
forms a heterotetramer in solution, consisting of its three protein components: Vps22, Vps36  
and two copies of Vps25 (Im and Hurley 2008). Vps36 contains a Gram-like ubiquitin-binding in 
Eap45 (GLUE) domain that binds ubiquitin and exhibits a weak preference for P13P. ESCRT-I 
and ESCRT-II may be somewhat involved in the creation of membrane curvature, but the main 
role of ESCRT-II seems to be to recruit ESCRT-III to the membrane and seed its polymerization 
via interactions between Vps25 and ESCRT-III component Vps20 (Schuh and Audhya 2014).  
 ESCRT-III assembles only on lipid bilayers, and does so via the sequential recruitment of 
its four components: Vps20, Vps32, Vps24 and Vps2 (Babst et al. 2002). Vps20 appears to be 
autoinhibited in the cytosol, but its recruitment by Vps25 to the endosomal membrane allows it 
to form an open conformation that promotes the assembly of ESCRT-III polymers. All 
components of ESCRT-III exhibit a similar structure, and are thought to adopt a 4-helix bundle 
configuration, with a fifth helix connected by a flexible linker (Muzioł et al. 2006; Bajorek et al. 
2009). These helical bundles polymerize into spiraling chains that deform the membrane, causing 
it to bud inward and form intraluminal vesicles carrying the cargo clustered by the earlier 
ESCRT components (Schuh and Audhya 2014).  
 During the budding of nascent vesicles into the interior of the MVB, the final component 
of the ESCRT pathway, the Vps4 complex, gets to work. This complex consists of Vps4 and its 
adaptor protein, Vta1. Vps4 is a type 1 AAA ATPase that forms dodecameric or tetradecameric 
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complexes with a central pore (Babst et al. 1998) that directly contacts ESCRT-III subunits and 
triggers their disassembly from the membrane, releasing ESCRT-III. In this model, the stepwise 
removal of ESCRT-III subunits from the polymer results in an ever-shrinking vesicle neck, 
which eventually closes to pinch off the vesicle inside the MVB (Babst et al. 1998; Schuh and 
Audhya 2014). 
 In order to create an MVB, this process is repeated until all of the ubiquitinated cargoes 
on the endosomal membrane are trapped in intraluminal vesicles (Wenzel et al. 2018). Although 
a single ubiquitin attached to a membrane protein is sufficient to activate this pathway, the 
affinity of ESCRT machinery for polyubiquitin chains is significantly higher (Ren and Hurley 
2010). In cells, the interactions of ESCRTs with ubiquitinated membrane proteins happens in 
equilibrium with those of DUBs, which remove ubiquitin from potential cargo, in order to 
establish the correct balance of membrane protein trafficking for degradation versus recycling. 
Mutation or deletion of ESCRT components, or an increase in DUB activity, will slow or halt the 
degradation of endolysosomal cargo (Shenoy and Lefkowitz 2003). In contrast, an increase in E3 
ligase activity or a decrease in DUB activity will speed degradation (McCullough, Clague, and 
Urbé 2004). However, some level of DUB activity is necessary for the creation of MVBs, as 
cargo must be deubiquitinated in order to release earlier ESCRTs and enable ILV formation 
(Henne, Buchkovich, and Emr 2011). This delicate balance must be maintained by all cells, and 
its disruption can have significant implications for cell health. 
 
Regulation of Membrane Protein Degradation 
 
The endolysosomal pathway mediates the degradation of ubiquitinated membrane-
associated proteins by orchestrating their recognition, capture, and sorting into multivesicular 
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bodies for delivery to lysosomes. All of these activities are carried out by the endosomal sorting 
complex required for transport (ESCRT) machinery described above. The ESCRT pathway is 
necessary for the homeostatic degradation of myriad membrane proteins, and this process is 
regulated by a complex variety of factors that differ depending on cell type (Schuh and Audhya 
2014). One of the best characterized cargoes of the ESCRT pathway is the epidermal growth 
factor receptor (EGFR). An intricate network of E3 ligases and DUBs regulates the 
ubiquitination of EGFR, most often with K63 polyubiquitination. Ubiquitin chains can be linked 
via different lysines, and it has been shown that different linkages result in divergent regulation 
in mammalian cells. Of the eight ubiquitin linkages, K63 linkages are one of the most common, 
and have been shown to play a proteasome-independent role in the cell. K63 linkages are instead 
involved in processes including endocytosis and selective autophagy (Ohtake et al. 2018; 
Husnjak and Dikic 2012), making them a prime candidate for the regulation of ESCRT cargoes 
like EGFR. Depletion of AMSH (associated molecule with SH3 domain of signal transducing 
adaptor molecule), a DUB that interacts directly with ESCRT components, speeds the 
degradation of EGFR, likely by slowing its rate of deubiquitination (McCullough, Clague, and 
Urbé 2004). However, another DUB involved in this process, UBPY (ubiquitin isopeptidase Y), 
has been shown to speed or slow EGFR degradation in different contexts (Bowers et al. 2006; 
Mizuno et al. 2005; Row et al. 2006), highlighting the complexity of the role of DUBs in ESCRT 
regulation. In terms of ubiquitination, both the Cbl and Nedd families of E3 ligases appear to 
play a role in stimulating the degradation of ESCRT cargo (Schuh and Audhya 2014). The many 
players involved in regulating ESCRT-mediated protein degradation, and the delicate balance of 
their actions even in simple eukaryotic cell types, underscores how much there is still to learn 
about ESCRT regulation in neurons. 
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ESCRT Pathway in Neurons 
 
Degradation of Synaptic Vesicle Proteins 
 
The inability to clear damaged or misfolded SV proteins can precipitate synaptic 
dysfunction and neurodegeneration (Bezprozvanny and Hiesinger 2013; Esposito, Ana Clara, 
and Verstreken 2012; Hall et al. 2017). However, the elaborate morphology of neurons creates 
unique spatial challenges for SV protein clearance and degradation. First, lysosomes - the 
degradative organelles for SV membrane proteins - are primarily localized to neuronal cell 
bodies, requiring retrograde transport of SV proteins destined for degradation. Second, the 
machinery responsible for packaging and delivering SV proteins to lysosomes must be 
anterogradely transported to presynaptic boutons. In addition to these spatial challenges, neurons 
face temporal challenges in transporting degradative machinery in response to stimuli such as 
synaptic activity. For instance, degradative organelles (proteasomes, lysosomes, and 
autophagosomes) undergo activity-dependent recruitment into the postsynaptic compartment as 
part of the mechanism for synaptic plasticity (Bingol and Schuman 2006; Goo et al. 2017; 
Shehata et al. 2012), and must be rapidly mobilized to these sites. Similarly, the turnover of SV 
and other presynaptic proteins is stimulated by neuronal activity (Sheehan et al. 2016; 
Truckenbrodt et al. 2018), requiring the local presence of degradative machinery to facilitate 
clearance of old and damaged proteins. However, very little is known about whether or how 
neurons regulate the transport and delivery of this machinery to presynaptic terminals.  
 Previous work from our group and others has demonstrated that the degradation of SV 
membrane proteins requires the endosomal sorting complex required for transport (ESCRT) 
pathway (Sheehan et al. 2016; Uytterhoeven et al. 2011). Sheehan et . al. showed that a 
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knockdown of ESCRT-0 protein Hrs slows the degradation of synaptic vesicle proteins, 
including SV2 and VAMP2. These findings, and the importance of the ESCRT pathway in 
neurons, is underscored by the clear connection between ESCRT dysfunction and 
neurodegeneration. 
 
Role in Neurodegeneration 
 
Studies in both animal models and humans have made it clear that the ESCRT pathway is 
vital for maintaining neuronal health. Mutation or dysfunction of various ESCRT-associated 
proteins leads to neurodegeneration in animal models (Tamai et al. 2008; J. A. Lee et al. 2007; 
D. Lee et al. 2019).  ESCRT dysfunction is also linked to frontotemporal dementia (FTD) 
(Skibinski et al. 2005; J. A. Lee et al. 2007), amyotrophic lateral sclerosis (ALS) (Parkinson et 
al. 2006) and infantile-lethal epilepsy (Hall et al. 2017) in humans. Moreover, the ESCRT 
pathway is essential for endosomal protein trafficking, and is implicated in the etiology of 
Alzheimer’s and Parkinson’s diseases (Vaz-Silva et al. 2018; Borland and Vilhardt 2017; 
Vagnozzi and Praticò 2019; Feng et al. 2020; Spencer et al. 2014, 2016). Yet despite the critical 
role of the ESCRT pathway in protein degradation and other cellular processes, as well as its 
links to neurodegenerative disease, little is known about its substrates, dynamic behavior, or 
mechanisms of localization and regulation in neurons.  
A previous study from our lab demonstrated that a subset of SV proteins are degraded in 
an activity-dependent manner, and that this process is initiated by the activation of small GTPase 
Rab35 and the recruitment of its effector, ESCRT-0 component Hrs (Sheehan et al. 2016). 
Interestingly, neuronal activity significantly increases the localization of Hrs to axons and SV 
pools, suggesting that ESCRT-0 proteins could be transported to SV pools in an activity-
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dependent manner to catalyze SV protein degradation. However, it is not clear how ESCRT-0 
proteins are transported into and out of synapses, leaving the questions of spatial and temporal 
regulation of neuronal ESCRTs unanswered. 
 
Endosomal Transport Dynamics 
 
Mechanics of Axonal Transport 
 
Axonal transport of cargoes anterogradely towards presynaptic boutons and retrogradely 
towards the soma is crucial for maintenance of synaptic health. The basics of axonal transport are 
the same for all cargoes. Anterograde transport is mediated by kinesins, and in neurons motors 
from the kinesin-1, kinesin-2, and kinesin-3 families all contribute to anterograde axonal 
transport. Retrograde transport is mediated by the singular dynein motor and facilitated by a 
wide variety of dynein adaptors. All motor proteins hydrolyze ATP to move progressively down 
a microtubule, towards the plus-end for kinesins, and the minus-end for dynein (Maday et al. 
2014). However, a more granular look at the dynamics and players involved in transport of 
individual cargoes shows that the regulation of axonal transport is complex and incredibly 
specific to individual cargoes, be they mitochondria, cytosolic proteins, synaptic vesicle 
precursors, mRNA, signaling endosomes, late endosomes, BDNF vesicles, early endosomes, or 
autophagosomes (Maday and Holzbaur 2016; Maday et al. 2014; Maday, Wallace, and Holzbaur 
2012; Obashi and Okabe 2013; M.-Y. Lin and Sheng 2015; K. Zhang et al. 2013; Bentley et al. 
2015; Goto-Silva et al. 2019). It is therefore clear that to understand the axonal regulation of an 







 It is evident from the literature that autophagosomes initiate in the distal axon, and are 
then transported retrogradely down the axon by dynein, acidifying into autolysosomes as they get 
to the soma (Maday, Wallace, and Holzbaur 2012; Maday and Holzbaur 2016; Kulkarni and 
Maday 2018a; Maday et al. 2014; Shehata et al. 2012; T. Wang et al. 2015; Borland and Vilhardt 
2017). Although autophagosomes interact with kinesin-1 and show some bidirectional movement 
immediately after formation in the distal axon, >80% eventually travel retrogradely to the soma 
(Maday et al. 2014). The major protein marker used to identify autophagosomes in imaging 
assays is LC3 (Maday and Holzbaur 2016; Maday, Wallace, and Holzbaur 2012), the lipidated 
form of which (LC3-II) is a widely cited, albeit slightly controversial (Kononenko et al. 2017; 
Okerlund et al. 2018; Waites et al. 2013), marker of autophagosomes (Kabeya 2000; Tanida, 




 Endosomes exhibit a much more complex axonal transport pattern. Late endosomes are 
generally marked by Rab7 and LAMP1 in the axon, and show limited catalytic activity, 
distinguishing them from the mature lysosomes found in the soma (K. Zhang et al. 2013; 
Deinhardt et al. 2006; Cheng et al. 2018; Kulkarni and Maday 2018b; Yap et al. 2018). Axonal 
late endosomes copurify with kinesin-1, 2, and dynein (Maday et al. 2014), and exhibit 
bidirectional transport. About half of these structures exhibit bidirectional motility characterized 
by frequent direction switching, and the other half display more progressive motility in either the 
anterograde or retrograde direction (Maday et al. 2014; Hendricks et al. 2010), although studies 
 
 22 
have highlighted the particular importance of their retrograde transport (Ferguson 2018). 
Interestingly, it has also been shown that autophagosomes may fuse with late endosomes in order 
to be transported in the retrograde direction (Cheng et al. 2015). Early endosomes, marked in the 
axon by Rab5, also exhibit a complex bidirectional motility, with biases towards anterograde or 
retrograde motility emerging in the presence of additional markers (Olenick, Dominguez, and 
Holzbaur 2018; Huckaba et al. 2011; Goto-Silva et al. 2019). These studies make it clear that in 
axons, Rab5 marks a diverse pool of vesicles ranging from signaling endosomes to classical 
early endosomes, all with unique patterns of motility. Thus, our understanding of the intricacies 





















Hippocampal neurons were prepared from E18 Sprague Dawley rat embryos of both 
sexes using a modified Banker culture protocol (Kaech & Banker, 2006, Nature Protocols; 
Sheehan et al., 2016, The Journal of Neuroscience; Waites et al., 2009, The Journal of 
Neuroscience). Neurons were dissociated in TrypLE Express (ThermoFisher/Invitrogen) for 
20min, washed with Hanks Balanced Salt Solution (Sigma), and plated in Neurobasal medium 
(ThermoFisher/Invitrogen) with N21 supplement (R&D Systems) and Glutamax 
(ThermoFisher/Invitrogen) at a density of 250,000 neurons per well (12 well plates), coverslip 
(22 x 22 mm square) or 35mm glass-bottom dish (MatTek), or at a density of 100,000 neurons 
per microfluidic chamber. Coverslips and dishes were pre-coated with 0.25 mg/ml poly-L-lysine 
(PLL) (Sigma-Aldrich) in 100 mM boric acid (pH 8.0) for 24 h before plating. 
 
Cell Lines 
Neuro2a (N2a) neuroblastoma cells (ATCC CCL‐131) and HEK293T cells (Sigma) were 
cultured in DMEM‐GlutaMAX (ThermoFisher/Invitrogen) with 10% FBS (Atlanta Biological) 




Microfluidic molds and chambers were prepared as described in (Birdsall et al., 2019). 
Master molds were prepared in a nanofabrication facility by repeatedly flooding SU-8 2050 over 
a silicon wafer and subjecting it to heat and UV light through a mask that outlines the mold 
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pattern (this step was completed by Lisa Randolph, Jose Martinez, and Ethan McCurdy in the lab 
of Ulrich Hengst at Columbia University). Once the molds were ready, they could be used 
repeatedly to construct chambers out of poly(dimethylsiloxane) (PDMS).  
Chambers were prepared by pouring ~30 ml of PDMS mixture (QSil 216) into molds, 
then baking. QSil 216 was weighed out in a 10:1 ratio of silicone polymer: curing agent in 
disposable plastic cup and mixed thoroughly for 2-5 min. The PDMS polymer solution was then 
vacuum mixed in a vacuum desiccator for 1 hour or until bubbles are mostly gone. The master 
mold was cleaned from dust and particles using tape, then the solution was carefully poured into 
the mold, and allowed to sit at room temperature for 2 min. The mold was then cured in a level 
laboratory oven for at least 3 h to overnight at 70°C. A razor blade was then used to cut around 
the inner edge of the mold and slowly remove the cured polymer piece. Individual chambers 
were then cut out using a razor blade, and channels were punched out channels using steel punch.  
To prepare chambers in dishes for cell seeding, glass-bottom dishes were incubated in 
PLL solution for >12 hours at 37°C, then washed 3x with deionized sterile water (dH2O) and 
dried. Chambers were sterilized by immersing briefly in 70% ethanol and dried fully in a laminar 
hood before use. The sterile, dried chambers and dishes were assembled by placing chamber 
lightly on glass, grooved side down. After assembly, channels were filled with warmed neuron 
culture media. Chambers were assembled chambers 3 - 24 h before seeding and placed in a 
humidified incubator at 37°C with 5% CO2. Next, a E18 rat hippocampal dissociated cell 
suspension was prepared (see Cell Culture), with an approximate density of 10,000 cells/ml of 
Plating media. Media was aspirated from chamber wells, cells were seeded into the two top left 
wells of a tripartite chamber, 70,000 cells in the upper left well, and 30,000 in the upper middle 
well (Figure 5). Chambers were placed back in incubator for 30 min to 1 h, then the remaining 
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wells were filled with Plating media. Plating media was removed and replaced with Neurobasal 
containing antibiotics 24 hours later. 
 




pVenus-2xFYVE was a gift from F. Polleux and was subcloned into pFUGWm vector 
(Waites et al. 2013) at MfeI/NheI sites; pFU-RFP-Hrs-W, pFU-STAM-mCh-W, pFU-
EGFP/mCh-Rab35, and pFU-EGFP/mCh-Rab5 were described in (Sheehan et al. 2016)); pFU-
EGFP-Synapsin-W was described in (Leal-Ortiz et al. 2008); and pBa-eGFP-flag-BicD2594-
FKBP (Addgene plasmid #63569; http://n2t.net/addgene:63569; RRID:Addgene_63569), pBa-
FRB-3myc-KIF13A tail 361-1749 (Addgene plasmid #64288; http://n2t.net/addgene:64288; 
RRID:Addgene_64288), and pBa-FRB-3myc-KIF13B tail 442-1826 (Addgene plasmid #64289; 
http://n2t.net/addgene:64289; RRID:Addgene_64289) were gifts from Gary Banker and Marvin 
Bentley (Jenkins et al. 2012; Bentley et al. 2015; Bentley and Banker 2015). Full-length human 
Hrs (NCBI accession #D84064.1) was synthesized at Genewiz and cloned into pFUGWm vector 
at BsrGI/XhoI sites to create pFU-EGFP-Hrs-W, and EGFP replaced with Halotag at the 
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AgeI/BsrGI sites to create pFU-Halo-Hrs-W. To create pFU-EGFP-R183A Hrs-W, an 868-
nucleotide fragment of Hrs containing the R183A mutation was synthesized at Genewiz and 
subcloned into the BsrGI/PshAI sites. shRNA scrambled control and KIF13A knockdown 
constructs (shCtrl, sh13A) were purchased from Origene (catalog #TL706020). The 29mer 
shRNA (lower-case letters) and surrounding loop sequences (capital letters) 
(shCtrl:CGGATCGgcactaccagagctaactcagatagtactTCAAGAG 
agtactatctgagttagctctggtagtgcTTTTT; sh13A:CGGATCGagccagacctctatgatagcaaccatcag 
TCAAGAGctgatggttgctatcatagaggtctggctTTTTTT) were then re-synthesized and subcloned into 




Pharmacological agents were used in the following concentrations and time courses: 
cycloheximide (Calbiochem, 0.2 µg/µl, 24 h), bicuculline (Sigma, 40 µM, 5 min-2 h), 4- 
aminopyridine (Tocris Bioscience, 50 µM, 5 min-2 h), D-AP5 (D-(-)-2-Amino-5-
phosphonopentanoic acid; Tocris Bioscience, 50 µM, 1 h), CNQX (6-Cyano-7-nitroquinoxaline-
2,3-dione; Tocris Bioscience, 10 µM, 1 h), TTX (Tetrodotoxin; Tocris Bioscience, 0.5 µM, 2 h), 
PR-619 (LifeSensors, 50 µM, 2 h), Rapamycin analogue linker drug (AP21967, Clontech, 100 
nM, 3 h), SAR405 (Millipore Sigma, 1 µM, 2 h). Unless otherwise indicated, all other chemicals 
were purchased from Sigma. 
 




Cell health in microfluidic chambers was evaluated using NucRed Dead 647 reagent to 
identify cells with compromised membranes along with membrane-permeant NucBlue™ Live 
ReadyProbes™ Reagent (both ThermoFisher) to evaluate the total number of cells. Neurons 
were treated with these reagents for 15 min then immediately imaged as described (see Live 
Neuron Imaging).  
 
Lentiviral Transduction and Neuronal Transfection 
 
Lentivirus was produced using HEK293T cells as previously described (Birdsall et al., 
2019; Sheehan et al., 2016). Briefly, HEK293T cells were plated in HEK cell media in a culture-
treated 10 cm dish, such that they would be 60-70% confluent at transfection. Media was 
changed prior to transfection. For each plate, a transfection mixture was set up in a 1.5 ml tube, 
containing: 1 ml DMEM (serum-free), 10 μg FUGW plasmid (containing the desired ESCRT 
construct), 7.5 μg delta P (packaging plasmid), 5 μg VsVg (envelope gene). Tubes were vortexed 
then spun down briefly before the addition of 35-40 μL of CalFectin reagent/tube. Tubes were 
incubated for 15 min at room temperature, then the mixture was added dropwise to 10 cm plate 
of HEK cells. 12-18 h after transfection, HEK cell media was removed and replaced with 8 mL 
of Neurobasal media. Virus was collected and filtered with a 0.45 μm filter 24 h after media 
change. Neurons were transduced with 50-150 µL of lentivirus on 7 DIV (days in-vitro), and 
imaged or fixed on 13-15 DIV. Lentivirus was fluidically isolated in chambers as previously 
described (Birdsall et al., 2019). Briefly, ~50% of the media from the wells to be infected was 
removed and placed in adjacent wells, then virus was infected into the reduced-volume wells to 
contain it within those compartments (Figure 5). 
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Neurons were transfected as described in (Sheehan et al. 2016) using Lipofectamine 2000 
(ThermoFisher/Invitrogen) on 9 DIV. Briefly, for each 22x22 mm coverslip or 35 mm dish, 2.5 
µL Lipofectamine was incubated with 62.5 µL Neurobasal for 5 min, combined with 2.5 µg 
DNA diluted into 62.5 µL Neurobasal for 15 min, then added to neurons for 1 h at 37°C. 
Neurons were transfected in Neurobasal medium containing 50 µM AP5 and 10 µM CNQX, 
washed 3X in this medium, and then returned to their original medium following transfection.  
 
Electron Micrograph Analysis of Endosomal Structures 
 
Electron microscopy of hippocampal synapses was performed by Glebov and Burrone as 
described (Glebov et al. 2016). Presynapses were defined visually by the presence of synaptic 
vesicle pools. Endosomal structures were defined as single-membraned structures with a 
diameter >80 nm. Multilamellar structures were defined as structures with more than one visible 
membrane. Synaptic area and endosomal/multilamellar structure size were measured using FIJI 
software. 
 
Correlative Light and Electron Microscopy  
 
For correlative fluorescence and electron microscopy experiments (performed by Yuuta 
Imoto in the lab of Shigeki Watanabe at John’s Hopkins University), mouse hippocampal 
neurons were cultured on sapphire disks (Technotrade #616-100) that were carbon-coated in a 
grid pattern (using finder grid masks; Leica microsystems, #16770162) to locate the region of 
interest by electron microscopy. Following 1 mg/mL poly-L-lysine (Sigma #P2636) coating 
overnight, neurons were seeded at densities of 2.5×102 cell/mm2 in 12-well tissue-culture treated 
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plates (Corning #3512) and cultured in NM0 medium (Neurobasal medium (Gibco #21103049) 
supplemented with 2% B27 plus (Life Technologies # A3582801) and 1% GlutaMAX (Thermo 
Fischer #35050061). STAM-Halo, HRS-Halo and vGlut1-pHluorin were lentivirally transduced 
at 6 DIV, and experiments performed at 14-15 DIV. To induce activity, 40 µM bicuculine (Bic) 
(Tocris #0130/50) and 50 µM 4-aminopyridine (4AP) (Tocris #940) were added to the culture 
media at 37C. Following 2 h incubation, half of the media was changed to NM0 with 2 mM 
Jenelia-Halo-549 nm (Lavis Lab #SB-Jenelia-Halo-549) and incubated for an additional 30 min 
at 37C. Neurons on the sapphire disks were washed 3X with PBS, fixed with 4% 
paraformaldehyde (EMS #15714) and 4% sucrose (Sigma #S0389) in PBS for 20 min at room 
temperature, washed again 3X with PBS, and mounted on a confocal scanning microscope (Carl 
Zeiss; LSM880) using a chamber (ALA science #MS-508S). Z-series of fluorescence images 
were acquired using a 40x objective lens at 2048x2048 pixel resolution. Differential interface 
contrast images of the carbon grid pattern and neurons on the sapphire disks were also acquired 
to locate the cells in later steps.  
 Following fluorescence imaging, neurons were prepared for electron microscopy. Here, 
sapphire disks were placed into 12-well plate containing 1 mL of 2% glutaraldehyde (EMS 
#16530) and 1 mM CaCl2 (Sigma-Aldrich # 63535) in 0.1 M sodium cacodylate (Sigma-Aldrich 
#C0250) pH 7.4 and incubated for 1 h on ice. Subsequently, the sapphire disks were washed with 
1 mL of chilled 1 M cacodylate buffer 3X for 5 min each. Neurons were then post-fixed for 1 h 
on ice with 2 mL of 1% osmium tetroxide (EMS #RT19134) and 1% potassium ferrocyanide 
(Sigma-Aldrich #P3289) in 0.1 M sodium cacodylate, pH 7.4. After washing 3X with 2 mL of 
water for 5 min, neurons were stained with 1 mL of 2% uranyl acetate (Polysciences #21447-25) 
in water for 30 min at room temperature and then briefly washed with 50% ethanol (Pharmco 
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#111000200) before dehydration in a graded ethanol series (50%, 70%, 90% for 5 min each, and 
100% for 5 min 3x). After dehydration, sapphire disks were embedded into 100% epon-araldite 
resin (Ted Pella #18005, 18060, 18022) with the following schedule and conditions: overnight at 
4 ºC, 6 h at room temperature (solution exchange every 2 h), and 48 h at 60 ºC.  
 For electron microscopy imaging, regions of interest were located based on the bright 
field images. When a sapphire disk is removed, neurons and carbon-coating remain in the plastic 
block, which was trimmed to the regions of interest and sectioned with a diamond knife using an 
ultramicrotome (Leica; UC7). Approximately 40 consecutive sections (80 nm each) were 
collected onto the pioloform-coated grids and imaged on a Phillips transmission electron 
microscope (CM120) equipped with a digital camera (AMT; XR80). The fluorescence and 
electron micrographs were roughly aligned based on size of the pixels and magnification, and the 





Neurons or N2a cells were immunostained as described previously (Leal-Ortiz et al. 
2008; Sheehan et al. 2016). Briefly, coverslips were fixed with Lorene’s Fix (60 mM PIPES, 25 
mM HEPES, 10 mM EGTA, 2 mM MgCl2, 0.12 M sucrose, 4% formaldehyde) for 15 min, 
incubated with primary and either Alexa-488- or Alexa-647-conjugated secondary antibodies 
diluted in blocking buffer (2% glycine, 2% BSA, 0.2% gelatin, 50 mM NH4Cl in PBS) for 1 h at 
room temperature, and washed 4X with PBS between antibody incubations. Coverslips were 
mounted with DAPI VectaShield (Vector Laboratories) and sealed with clear nail polish. 
Alternatively, coverslips were mounted with Aqua-Poly/Mount (Polysciences) and dried 
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overnight in the dark. Images were acquired with a 40x objective (Neofluar, NA 1.3) or 63x 
objective (Neofluar, NA 1.4) on an epifluorescence microscope (Axio Observer Z1, Zeiss) with 
Colibri LED light source, EMCCD camera (Hamamatsu) and Zen 2012 (blue edition) software. 
Images were obtained and processed using Zen Blue 2.1 software. Image processing was done 
using FIJI (Image-J) software.  
 
In vitro KIF13A/KIF13B transport assay  
 
N2a cells were transfected at 50-70% confluence with BicD2-GFP-FKBP, KIF13A-FRB-
Myc or KIF13B-FRB-Myc, and either mCherry, mCh-Rab5, RFP-Hrs, or STAM-mCh, using 
Lipofectamine 3000 (ThermoFisher/Invitrogen) according to manufacturer’s instructions. After 
48 h, rapamycin analogue (AP21967) or EtOH control was added to relevant samples as 
described in (Bentley and Banker 2015). After 3 h of treatment, cells were fixed and imaged as 
described in Immunofluorescence Microscopy.   
 
Live Imaging  
 
Neurons were imaged at 12-15 DIV after being transduced on 7 DIV, or transfected at 9 
DIV. Imaging was conducted in pH-maintaining Air Media, consisting of 250 mL  L15 Media 
(ThermoFisher/Invitrogen) and 225 mL Hanks Balanced Salt Solution (Sigma), supplemented 
with 55 mM HEPES, 2% B27 (ThermoFisher), 0.5mM GlutaMAX (ThermoFisher), 0.1% 
Pen/Strep, 0.5% Glucose, and 2.5% BME. Neurons were imaged at 37°C with a 40x oil-
immersion objective (Neofluar, NA 1.3) on an epifluorescence microscope (Axio Observer Z1, 
Zeiss) with Colibri LED light source, EMCCD camera (Hamamatsu) and Zen 2012 (blue edition) 
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software. One frame was taken every 5 seconds, for a total of 50 frames. Images were obtained 
and processed using Zen Blue 2.1 software. Axons were identified via location and 
morphological criteria. Image processing was done using FIJI (Image-J) software. 
 
Live Imaging Analysis 
 
Motility of axonal puncta was analyzed using FIJI’s “Manual Tracker” plugin. Raw data 
for the movement of each puncta over each video frame were imported into Matlab and motility, 
directionality, and speed were calculated using a custom program. Only puncta ≥0.5 microns and 
<1.5 microns in diameter were analyzed. Directionality of each puncta was categorized as 
follows: ≥4 µm away from the cell body = anterograde, ≥4 µm towards the cell body = 
retrograde, ≥4 µm total, but <4 µm in one direction = bidirectional, <4 µm = stationary. Axon 
length was measured with FIJI software.  
 
Immunoprecipitation and Western Blot 
 
For immunoprecipitation assays, N2a cells were transfected at 50-70% confluence using 
Lipofectamine 3000 (ThermoFisher/Invitrogen) according to manufacturer’s instructions. Cells 
were collected 48 h later in lysis buffer (50 mm Tris-Base, 150 mm NaCl, 1% Triton X-100, 
0.5% deoxycholic acid) with protease inhibitor mixture (Roche) and clarified by centrifugation at 
high speed (20,000 x g). Resulting supernatant was incubated with Dynabeads 
(ThermoFisher/Invitrogen) coupled to anti-mCherry antibodies (polyclonal; Biovision). Lysates 
and beads were incubated at 4°C under constant rotation for 2 h. Beads were washed 2–3X with 
PBS containing 0.05% Triton (PBST) and then once with PBS. Bound proteins were eluted using 
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sample buffer (Bio-Rad) and subject to SDS-PAGE immunoblotting as described following. For 
High K+ stimulation of N2a cells, cells were incubated with a High K+ Tyrodes Solution (31.5 
mM NaCl, 50 mM KCl, 2 nM MgCl2, 2 mM CaCl, 25 mM HEPES pH 7.4, 30 mM glucose), or a 
Control Tyrodes (119 mM NaCl, 2.5 mM KCl, 2 nM MgCl2, 2 mM CaCl, 25 mM HEPES pH 
7.4, 30 mM glucose) for 2 h at 37°C before collection in lysis buffer. For all other 
immunoblotting experiments, neurons were collected directly in 2X SDS sample buffer (Bio-
Rad). Samples were subjected to SDS-PAGE, transferred to nitrocellulose membranes, and 
probed with primary antibody in 5% BSA/PBS + 0.05% Tween 20 overnight at 4°C, followed by 
DyLight 680 or 800 anti-rabbit, anti-mouse, or anti-goat secondary antibodies (ThermoFisher) 
for 1 h. Membranes were imaged using an Odyssey Infrared Imager (model 9120, LI-COR 




All statistical analyses were performed using GraphPad Prism software. Statistics for 
each experiment are described in the Figure Legends. A D’Agostino-Pearson normality test was 
used to assess normality. An unpaired Student’s t test or a Mann–Whitney U test was used to 
compared two datasets, and an ANOVA or a Kruskal-Wallis test was used to compare three or 
more datasets. For multiple comparisons, Dunnett’s or Dunn’s post-hoc test was used to compare 
a control mean to other means, while Sidak’s post-hoc test was used to compare pairs of means. 
Statistical significance is noted as follows (and in Figure Legends): ns, P>0.05; *, P≤0.05; **, 
P≤0.01; ***, P≤0.001. All experiments were repeated with at least 3 independent sets of 





Chapter 3: ESCRT-0 proteins Hrs and STAM are bidirectionally motile in 




Previous work (Sheehan et al. 2016) suggests that high levels of neuronal firing increase 
the axonal and synaptic localization of ESCRT proteins Hrs and CHMP2B (the mammalian 
homologue of ESCRT-III protein VPS2). This suggests that ESCRT proteins undergo activity-
dependent changes in their motility and transport to synapses. As ESCRT-0 is responsible for the 
recruitment of the rest of the ESCRT pathway to specific endosomal sites, we hypothesized that 
this component would show the most robust response to neuronal firing. ESCRT-0 protein Hrs is 
the first component of the ESCRT pathway, responsible for sequestering ubiquitinated cargo and 
recruiting subsequent ESCRT machinery, steps that necessarily precede endolysosomal 
degradation of SV and other membrane proteins. Thus, we first examined the axonal transport 
dynamics of Hrs, followed by its binding partner STAM1. We found that the axonal motility of 
both ESCRT-0 proteins was highly responsive to neuronal firing. To determine whether the 
transport of other components of the ESCRT pathway is sensitive to neuronal activity, we next 
examined the axonal dynamics of ESCRT-I protein TSG101 and small Rab GTPase Rab35 at 
baseline and in response to activity. TSG101 interacts with both Hrs and ubiquitinated cargo on 
the endosomal membrane, while Rab35 binds Hrs in response to activity, and is involved in 
ESCRT-mediated degradation of synaptic vesicle proteins (Sheehan et al. 2016). Of these 
proteins, ESCRT-0 components alone are sensitive to high levels of neuronal activity, suggesting 






Hrs and STAM are bidirectionally motile at baseline, and exhibit increased motility in response 
to neuronal firing 
 
To facilitate analysis of the directional movement of Hrs and other proteins in axons, we 
utilized tripartite microfluidic chambers that isolate neuronal cell bodies from axons while 
enabling synapse formation between neurons in adjacent compartments (Figure 5). Mature 
synapses are able to form in cell body compartments, but do not form in the axonal microgrooves 
because dendrites cannot enter. Lentiviral transduction of cell bodies in these chambers led to 
moderate protein expression levels and consistent transduction efficiency across constructs used 
in this study (~50%; Figure 6A). Hippocampal neurons were transduced on 7 DIV with RFP-Hrs, 
and live imaging of axons was performed on 13-15 DIV. Axons were imaged in a window that 
extended at the minimum from 0 to 200 microns from the soma, dependent on the location of the 
cell body, which was not recorded. Imaging was performed either immediately following 
application of DMSO (control) or bicuculline and 4-aminopyridine (acute Bic/4AP), or after 2 
hours of treatment with these drugs (2h Bic/4AP)((Sheehan et al. 2016); Figure 7A-C). Bic/4AP 
treatments did not cause any detectable changes in neuronal health or increase cell death over 
this timeframe (Figure 6B). Under control conditions, we observed that >60% of Hrs puncta 
were stationary over the course of the ~4-minute imaging session (Figure 7A, D). Acute 
treatment with Bic/4AP led to a slight but significant increase in puncta motility (from ~38% to 
~50% motile), with the effect growing stronger after 2h of treatment (~60% motile puncta; 
Figure 7B-D). No change in speed was observed across the three conditions (Figure 7E), nor was 
there an increase in total axonal Hrs (Figure 7G) indicating that activity leads to the recruitment 
of Hrs puncta into the motile pool rather than to a fundamental change in the mechanism of 
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transport. Interestingly, dampening neuronal activity with 2 h TTX treatment, which prevents 
neuronal firing, did not conversely decrease Hrs motility (Figure 6C), indicating that basal 
activity levels in these cultures are low. A breakdown of the directionality of Hrs puncta shows 
that they exhibit a mixture of anterograde, retrograde, and non-processive bidirectional motility 
(Figure 7F). However, we found that only anterograde and bidirectional motility increase 
following treatment with Bic/4AP (Figure 7F), suggesting that neuronal activity preferentially 
mobilizes Hrs towards distal axonal and presynaptic sites. 
 
Figure 6. Characterization of cell health, lentiviral transduction efficiency, and neuronal activity 
effects in microfluidic chambers. (A) Lentiviral transduction efficiency of neurons in microfluidic 
chambers. Graph shows a similar percentage of cell bodies transduced for each lentivirus (≥3 separate 
experiments, n=28 (Hrs), 23 (STAM), 26 (Rab5), 29, (Rab35)). (B) Analysis of neuronal health in 
chambers. Graph shows percentage of cells that exhibit NucRed Dead fluorescence following 
treatments, which is similar across conditions (P>0.05, one-way ANOVA with Dunnett's multiple 
comparisons test; ≥3 separate experiments,  n=33 (control), 24 (acute activity), 31 (2 h activity) 
videos/condition). (C) Percentage of axonal Hrs puncta that exhibit motility under control conditions, 2 
h Bic/4AP treatment, and 2 h TTX treatment to block neuronal activity. TTX treatment does not alter 
puncta motility compared to the control condition (*P<0.05, one-way ANOVA with Dunnett's multiple 
comparisons test; ≥3 separate experiments,  n=10 (control), 15 (2 h Bic/4AP), 1 (2 h TTX) 
videos/condition). 
 
We next characterized the axonal motility of STAM1, which is recruited to endosomal 
membranes by Hrs to form the heterotetrameric ESCRT-0 complex (Mayers et al. 2011; 
Takahashi et al. 2015). We found that STAM1, like Hrs, has a punctate pattern of expression in 
 
 37 
axons, with similar dynamics to Hrs at baseline (~40% of puncta motile; Figure 7H) and an even 
larger increase in motility after 2 h of Bic/4AP (~80% motile; Figure 7J). Also similar to Hrs, 
Bic/4AP treatment did not alter the average speed of motile STAM1 puncta, which remained 
~0.3 m/second (Figure 7L) and yielded only a slight increase in the total number of axonal 
STAM1 puncta after 2 h of Bic/4AP (Figure 7N). The increase in the fraction of anterogradely 
moving puncta was even more pronounced for STAM1 than for Hrs and was accompanied by an 
increase in retrograde puncta movement (Figure 7M). These findings indicate that the motility of 






Figure 7. Neuronal activity stimulates the transport of ESCRT-0+ vesicles in axons. (A-C) 
Representative images and corresponding kymographs of microfluidically isolated axons from 13-15 
DIV hippocampal neurons transduced with RFP-Hrs, under control conditions (A), acute treatment 
with Bicuculline/4AP (B), and 2 h treatment with Bicuculline/4AP (C). Scale bar, 10 µm. (D) 
Percentage of motile Hrs puncta in axons, showing a significant increase with acute and 2 h Bic/4AP 
treatment (****P<0.0001, *P<0.05; one-way ANOVA with Dunnett's multiple comparisons test; ≥3 
separate experiments, n=20 (control), 15 (acute Bic/4AP), 16 (2 h Bic/4AP) videos/condition). (E) 
Average speed of motile Hrs puncta (µm/sec), showing no change across conditions. Same ‘n’ values 
as D. (F) Breakdown of directional movement of Hrs puncta, expressed as percentage of total Hrs 
puncta. Anterograde and bidirectional movement are significantly increased following 2 h Bic/4AP 
treatment (****P<0.0001, ***P<0.001, **P<0.01, one-way ANOVA with Dunnett's multiple 
comparisons test; same ‘n’ values as D). (G) Total number of Hrs-positive puncta in axons, showing no 
change across conditions. Same ‘n’ values as D. (H-N) Representative images and corresponding 
kymographs of microfluidically isolated axons from 13-15 DIV hippocampal neurons transduced with 
STAM1-mCh, under control (H), acute Bic/4AP (I), and 2 h Bic/4AP (J) conditions. Scale bar, 10 µm. 
(K) Percentage of motile STAM1 puncta in axons, showing a significant increase with acute and 2 h 
Bic/4AP treatment (****P<0.0001,**P<0.01, *P<0.05, one-way ANOVA with Dunnett's multiple 
comparisons test; ≥3 separate experiments, n=32 (control), 36 (acute Bic/4AP), 13 (2 h Bic/4AP) 
videos/condition). (L) Average speed of motile STAM1 puncta (µm/sec), showing no change across 
conditions. Same ‘n’ values as K. (M) Breakdown of directional movement of STAM1 puncta, 
showing that anterograde, retrograde, and bidirectional movement are all significantly increased 
following 2 h  Bic/4AP treatment (****P<0.0001, ***P<0.001, **P<0.01, *P<0.05, one-way ANOVA 
with Dunnett's multiple comparisons test; same ‘n’ values as K). (N) Total number of STAM1-positive 
puncta in axons, showing only a small change after 2 h Bic/4AP (*P<0.05, one-way ANOVA with 
Dunnett's multiple comparisons test; same ‘n’ values as K).  
 
ESCRT-I component TSG101 and small GTPase Rab35 do not show activity-dependent motility 
changes 
 
 Using the microfluidic system described above, we then characterized the axonal motility 
of EGFP-TSG101. We found that TSG101 looked significantly less punctate in neurons than 
ESCRT-0 proteins. This distribution may indicate that ESCRT-I does not stably associate with 
the membrane in the absence of ESCRT-0, which we were not concurrently overexpressing 
(Figure 8G-I). However, there were enough TSG101 puncta in the axon to enable their tracking 
and analysis. We found that TSG101 had similar baseline levels of activity to ESCRT-0 proteins 
(~40% of puncta motile; Figure 8A) but did not show an activity-dependent change in motility, 
speed, or number of puncta per 100 µm axon (Figure 8A-F). Indeed, the only difference in 
TSG101 motility between control and high-activity conditions was a slight increase in 
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bidirectional motility after 2 h of Bic/4AP treatment (Figure 8E). This led us to conclude that the 
motility of TSG101 is either not significantly altered by neuronal activity, or that the effect 
appears only after more prolonged neuronal firing. The latter possibility could be the purview of 




Figure 8. ESCRT-I protein TSG101 shows little change in motility in response to neuronal 
activity. (A-B) Representative images and corresponding kymographs of microfluidically isolated 
axons from 13-15 DIV hippocampal neurons transduced with EGFP-TSG101, under control conditions 
(A) and after 2 h treatment with Bicuculline/4AP (B). Scale bar, 10 µm. (C) Percentage of motile 
TCG101+ puncta in axons, showing no significant increase with acute or 2 h Bic/4AP treatment 
(P>0.05; one-way ANOVA with Dunnett's multiple comparisons test; ≥3 separate experiments, n=30 
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(control), 33 (acute Bic/4AP), 14 (2 h Bic/4AP) videos/condition). (D) Average speed of motile 
TSG101+ puncta (µm/sec), showing no change across conditions. Same ‘n’ values as C. (E) Breakdown 
of directional movement of TSG101 puncta, expressed as percentage of total TSG101+ puncta. Only 
bidirectional movement is significantly increased following 2 h of Bic/4AP treatment (*P<0.05, one-
way ANOVA with Dunnett's multiple comparisons test; same ‘n’ values as C). (F) Total number of 
TSG101+ puncta in axons, showing no change across conditions. Same ‘n’ values as C. (G-H) 
Representative images from neurons 12 DIV co-transfected with RFP-Hrs (G) and EGFP-TSG101 (H). 
Arrows show colocalized puncta. TSG101 becomes more punctate and exhibits strong colocalization 
with Hrs when they are co-transfected. (I) Representative images of EGFP-TSG101 in the absence of 
Hrs, showing a more diffuse expression pattern. 
 
 Given our previous findings that Rab35 is present on the same vesicles as Hrs and is 
required for activity-dependent degradation of SV proteins (Sheehan et al. 2016), we also 
investigated the transport dynamics of axonal Rab35. We found that EGFP-Rab35 exhibited 
higher motility than Hrs at baseline (~60% motile, Figure 9A), but no change in motility in 
response to Bic/4AP, even after 2 h of treatment (Figure 9A-G). However, the colocalization 
between RFP-Hrs and EGFP-Rab35 in axons increased slightly but significantly in response to 2 
h Bic/4AP (Figure 9H-I). These data, along with similarities in the directional transport profiles 
of Hrs and Rab35 following 2 h Bic/4AP treatment (Figure 7F & Figure 9F), suggest that Rab35 
colocalizes more strongly with the motile pool of Hrs, and that its motility is not regulated by 




Figure 9. Neuronal activity does not stimulate Rab35 motility in axons. (A-C) Representative 
images and corresponding kymographs for 13-15 DIV hippocampal axons transduced with EGFP-
Rab35, under control conditions (A), acute treatment with Bicuculline/4AP (B), and 2 h treatment with 
Bicuculline/4AP (C). Scale bar, 10 µm. (D) Percentage of motile Rab35+ puncta in axons, showing no 
significant difference across conditions (P>0.05, Kruskal-Wallis test with Dunn's multiple comparisons 
test; ≥3 separate experiments, n= 20 (control), 15 (acute Bic/4AP), 20 (2 h Bic/4AP) videos/condition). 
(E) Average speed of motile Rab35+ puncta (µm/sec), showing no change across conditions. Same ‘n’ 
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values as D. (F) Breakdown of directional movement of Rab35+ puncta, expressed as percentage of 
total puncta, showing no change across conditions. (G) Representative images of fixed hippocampal 
axons expressing RFP-Hrs and EGFP-Rab35. Scale bar, 10 µm. (H) Percentage of Hrs puncta that are 
positive for Rab35, showing increased colocalization following 2 h Bic/4AP treatment (*P<0.05, one-
way ANOVA with Dunnett's multiple comparisons test; ≥3 separate experiments, n=36 (control), 39 (2 




Altogether, these results suggest that of the ESCRT-0 and -I components and related Rab 
GTPase characterized here, only ESCRT-0 proteins Hrs and STAM1 show a strong response to 
neuronal firing. These findings indicate that the axonal motility of ESCRT-0 proteins may be 
uniquely regulated by neuronal activity. This study is the first to investigate the motility of 
ESCRT components in neurons and has yielded interesting information about the behavior of 
these proteins in axons. In contrast to the highly processive motility of autophagosomes (0.45 
µm/s) (Maday, Wallace, and Holzbaur 2012; Maday and Holzbaur 2016; Maday et al. 2014), we 
find that ESCRT proteins exhibit more complex bidirectional motility, as well as more stationary 
behavior in axons (Figure 7F&M, Figure 8E). These findings suggest not only that distinct 
axonal motor proteins are responsible for the transport of endolysosomal versus autophagic 
structures, but also that these pathways may have divergent roles at the presynapse. In contrast to 
the constitutive formation and flow of autophagosomes from presynaptic terminals to the soma, 
which is unaffected by stimuli such as starvation or neuronal activity (Maday, Wallace, and 
Holzbaur 2012; T. Wang et al. 2015), the transport of ESCRT proteins appears to be more 
heterogeneous and susceptible to regulation. This work further demonstrates the distinctive 
dynamics and roles of the autophagic and ESCRT degradative machinery in neurons, potentially 
illuminating the roles of each pathway in the degradation of synaptic vesicle proteins under 
different conditions (Hernandez et al. 2012; Sheehan et al. 2016; Uytterhoeven et al. 2011, 2017; 
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Vijayan and Verstreken 2017; Birdsall and Waites 2019). However, more work is needed to fully 
dissect the substrates and functions of these interconnected pathways.  
It is also significant that the activity-dependent changes in motility are observed for 
ESCRT-0 but not ESCRT-I proteins. Given the layered recruitment of ESCRT complexes to the 
endosomal membrane (Katzmann, Babst, and Emr 2001; Henne, Buchkovich, and Emr 2011; 
Raiborg, Rusten, and Stenmark 2003; Schuh and Audhya 2014), it is possible that later 
complexes do not need to be responsive to neuronal firing, as recruitment of ESCRT-0 will 
initiate recruitment of the rest of the pathway. Indeed, many downstream ESCRT proteins cannot 
stably associate with membranes in the absence of an ESCRT-0 interaction. It is also possible 
that downstream ESCRT components are responsive to activity, but over a longer time-course 
than assessed in our experiments. Future work will address this possibility by further 
characterizing the axonal transport and motility of ESCRT-II and -III proteins. 
Finally, the relationship between neuronal activity and Rab35 localization and transport 
remains murky. Although the motility of Rab35 appears to be unaffected by neuronal firing 
(Figure 9), our previous findings that Rab35 and Hrs localize to the same vesicles (Sheehan et al. 
2016), as well as the uncanny similarities between the transport profiles of Hrs under high-
activity conditions and Rab35 across conditions (Figure 7F,Figure 9F) and the increased 
colocalization of Hrs with Rab35 in response to activity (Figure 9H-I), all suggest a possible 
recruitment of Hrs to Rab35+ vesicles in response to activity. This would be consistent with the 
fact that Hrs is an effector of Rab35, and is recruited by GTP-Rab35 in response to neuronal 










Hrs typically associates with early endosomes (Sun et al. 2003; Raiborg, Rusten, and 
Stenmark 2003; Flores-Rodriguez et al. 2015; Raiborg et al. 2001); thus, we examined whether 
other early endosomal proteins exhibit similar transport dynamics and activity-dependent 
motility. Along with the ESCRT-0 complex, another key component of early endosomes, critical 
for their formation and function, is the small GTPase Rab5 (Gorvel et al. 1991; Deinhardt et al. 
2006; Poteryaev et al. 2010). We therefore investigated the motility of Rab5 under control and 
activity conditions. After observing that the Rab5 motility profile and response to activity did not 
mirror those of ESCRT-0 proteins, we hypothesized that axonal ESCRT-0+ vesicles, 
characterized here for the first time, could represent specialized ‘pro-degradative’ endosomes. To 
address this hypothesis, we investigated the colocalization of Hrs with Rab5, as well as the 
mechanism that targets Hrs to vesicle membranes. We find that axonal Hrs+ vesicles are a subset 
of Rab5+ vesicles, and that Hrs association with vesicle membranes requires the canonical 




Figure 10. Rab5+ vesicles show a modest increase in motility in response to heightened neuronal 
activity. (A-C) Representative images and corresponding kymographs of microfluidically isolated 
axons from 13-15 DIV hippocampal neurons transduced with EGFP-Rab5, under control (A), acute 
Bic/4AP (B), and 2 h Bic/4AP (C) conditions. Scale bar, 10 µm. (D) Percentage of motile Rab5 puncta 
in axons, showing a significant increase only after 2 h Bic/4AP treatment (**P<0.01, Kruskal-Wallis 
test with Dunn's multiple comparisons test; ≥3 separate experiments, n=31 (control), 30 (acute 
Bic/4AP), 14 (2 h Bic/4AP) videos/condition). (E) Average speed of motile Rab5+ puncta (µm/sec) is 
unchanged across conditions, as with Hrs and STAM1. Same ‘n’ values as I. (F) Breakdown of 
directional Rab5+puncta movement, showing that only anterograde movement is significantly increased 
following 2 h Bic/4AP treatment (**P<0.01, *P<0.05, one-way ANOVA with Dunnett's multiple 
comparisons test; same ‘n’ values as I). All scatter plots and bar graphs show mean ± SEM. (G) Total 







Rab5 shows a modest activity-dependent increase in axonal motility 
 
Utilizing the microfluidic chambers described in Chapter 3, we found that EGFP-Rab5 
exhibited higher motility under control conditions than ESCRT-0 proteins (~60% motile puncta 
at baseline; Figure 10A,D), and that the motility of Rab5 puncta did not increase with acute 
Bic/4AP treatment (Figure 10B,D), in contrast to Hrs and STAM1. However, after 2h of 
Bic/4AP, Rab5 puncta exhibited significantly increased motility, to ~80% motile puncta (Figure 
10C-D). As with Hrs and STAM1, the average speed and number of axonal Rab5 puncta was 
unaffected by activity treatment (Figure 10E,G). The proportion of anterogradely moving Rab5 
puncta also increased significantly after 2 h of Bic/4AP treatment (Figure 10F) and was the only 
observed change in Rab5 directional movement. These data show that while Rab5 puncta do 
exhibit activity-induced changes in axonal motility, this effect takes longer to materialize and is 





Figure 11. Hrs is present on a subset of Rab5+ vesicles in axons. (A) Representative images and 
corresponding kymographs for 13-15 DIV hippocampal axons co-transfected with RFP-Hrs and EGFP-
Rab5. Arrows show puncta that are positive for both proteins. Scale bar, 10 µm. (B) Percentage of 
stationary Hrs puncta that are also positive for Rab5, demonstrating no significant difference across 
conditions (P>0.05, one-way ANOVA with Dunnett's multiple comparisons test; ≥3 separate 
experiments, n=14 (control), 18 (acute Bic/4AP), 12 (2 h Bic/4AP) videos/condition). (C) Percentage 
of stationary Rab5+ puncta that are also positive for Hrs, demonstrating no significant differences 
across condition. Same ‘n’ values as B. (D) Percent of stationary puncta that are positive for both Hrs 
and Rab5 per 100 µm of axon, showing no significant differences across conditions. Same ‘n’ values as 
B.  (E) Percentage of motile Hrs+ puncta that are positive for Rab5, showing a significant increase in 
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motility after 2 h of Bic/4AP treatment (*P<0.05, Kruskal-Wallis test with Dunn’s multiple 
comparisons test; same ‘n’ values as B). (F) Percentage of motile Rab5 puncta that are also positive for 
Hrs, showing no significant difference in motility across conditions. Same ‘n’ values as B. (G) 
Percentage of motile puncta that are positive for both Hrs and Rab5 per 100 µm of axon, showing a 
significance increase in motility after 2 h of Bic/4AP treatment (**P<0.01, one-way ANOVA with 
Dunnett's multiple comparisons test; same ‘n’ values as B). All scatter plots show mean ± SEM. 
 
Hrs+ vesicles are a subset of Rab5+ vesicles 
 
Since the axonal dynamics of Rab5 do not precisely align with those of ESCRT-0 
proteins, we next investigated whether Hrs is present on the same vesicles as Rab5 in axons. 
Here, we performed time-lapse imaging of axons from dissociated neurons co-transfected with 
RFP-Hrs and EGFP-Rab5 (Figure 11A). The density of Rab5+ puncta in co-transfected axons 
was on average higher than that of Hrs+ puncta, and while >80% of Hrs+ puncta (stationary and 
motile) were also positive for Rab5 (Figure 11B,E), the converse was not true. Indeed, only 
~40% of stationary Rab5+ puncta and ~60% of motile Rab5 puncta were positive for Hrs (Figure 
11C,F). These data suggest that Hrs is present on a subset of Rab5+ structures, consistent with 
previous studies showing that Rab5 is associated with a heterogenous population of endosomes 
as well as SVs (Simonsen et al. 1998; Christoforidis et al. 1999; Flores-Rodriguez et al. 2015; 
Fischer von Mollard et al. 1994; Shimizu, Kawamura, and Ozaki 2003; K. Zhang et al. 2013). 
Moreover, while the total number (stationary and motile) of Hrs+/Rab5+ puncta did not change in 
response to neuronal activity (Figure 11D), the number of motile Hrs+/Rab5+ puncta increased 
significantly (Figure 11G). These findings indicate that an Hrs+ subset of Rab5+ vesicles is 
responsive to neuronal firing, providing a potential explanation for why the total population of 





Figure 12. Hrs 2xFYVE domain does not recapitulate the motile behavior of full-length Hrs. (A-
C) Representative images and corresponding kymographs for 13-15 DIV hippocampal axons 
transduced with EGFP-2xFYVE domain, under control conditions (A), acute treatment with Bic/4AP 
(B), and 2 h treatment with Bic/4AP (C). Scale bar, 10 µm. (D) Percentage of motile 2xFYVE puncta 
in axons, showing no significant difference across conditions (P>0.05, one-way ANOVA with 
Dunnett's multiple comparisons test; ≥3 separate experiments, n=11 (control), 12 (acute Bic/4AP), 10 
(2 h Bic/4AP) videos/condition). (E) Average speed of motile 2xFYVE+ puncta (µm/sec), showing no 
change across conditions. Same ‘n’ values as D. (F) Breakdown of directional movement of 2xFYVE+ 
puncta, expressed as percentage of total puncta, showing no change across conditions. All scatter plots 
and graphs show mean ± SEM. (G) Total number of 2xFYVE+ puncta in axons, showing no change 







Figure 13. Hrs vesicle association requires FYVE domain/PI3P interactions and occurs in the 
somatodendritic compartment. (A-C) Representative images of EGFP-Hrs localization in cell bodies 
and dendrites of 13-15 DIV hippocampal neurons under control conditions (A), after 2 h of SAR405 
treatment (B), and with the R183A FYVE domain inactivating mutation (C). (D) Number of Hrs 
puncta/µm2 in the somatodendritic compartment under these conditions, demonstrating significant 
decreases in puncta density with SAR405 treatment or R183A mutation (***P<0.001, *P<0.05,  one-
way ANOVA with Dunnett's multiple comparisons test; ≥3 separate experiments, n=33 (control), 35 (2 
h SAR405), 17 (FYVE mutant) images/condition). (E-F) Representative images and corresponding 
kymographs of microfluidically isolated hippocampal axons transduced with EGFP-Hrs, under control 
conditions (E) and after 2 h of treatment with SAR405 (F). (G) Number of total Hrs puncta per 100 µm 
of axon, showing no significant difference across these conditions (P>0.05, unpaired t-test; ≥3 separate 
experiments, n=11 (control), 10 (2 h SAR405) videos/condition). (H) Average speed of motile Hrs 
puncta (µm/sec), showing no difference following SAR405 treatment. Same ‘n’ values as B. (I) 
Percentage of motile Hrs puncta in axons, showing no difference following SAR405 treatment. Same 
‘n’ values as B. All scatter plots show mean ± SEM. 
 
Hrs targeting to vesicle membranes depends on the FYVE domain/PI3P interaction and occurs in 
the soma  
 
Studies in non-neuronal cells show that Hrs recruitment to endosomal membranes 
depends on interactions between its FYVE domain and the endosome-enriched lipid 
phosphoinositol-3-phosphate (PI3P) (Komada & Soriano, 1999; Stahelin et al., 2002). However, 
other domains of Hrs, in particular the C-terminal coiled-coil domain, have also been reported to 
facilitate its membrane targeting (Hayakawa & Kitamura, 2000; Raiborg et al., 2001). Given the 
dearth of evidence about axonal targeting of Hrs, and reports that EEA1, another FYVE domain 
early endosomal protein, is not present in axons (Gaullier et al., 2000; Lawe et al., 2000; Wilson 
et al., 2000), we wanted to investigate whether the FYVE/PI3P interaction was required for 
vesicular targeting of axonal Hrs. We first assessed whether the axonal dynamics of the Hrs 
FYVE domain replicated those of full-length Hrs. Here, neurons in microfluidic chambers were 
lentivirally transduced with EGFP-2xFYVE, and their dynamic behavior assessed under control, 
acute Bic/4AP, and 2 h Bic/4AP conditions. Interestingly, while the 2xFYVE domain exhibited 
highly punctate expression in axons, its dynamics were different from those of full-length Hrs 
and it did not demonstrate activity-dependent changes in motility (Figure 12A-G), indicating that 
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other domains of Hrs facilitate its activity-dependent transport. We next assessed whether the 
FYVE/PI3P interaction was necessary for targeting Hrs to vesicle membranes in neurons. For 
these experiments, we treated EGFP-Hrs-expressing neurons with an inhibitor of the 
phosphatidylinositol 3-kinase VPS34, required for synthesis of PI3P (SAR405; (Schu et al. 
1993)). Two hours of treatment with the inhibitor dramatically decreased the number of 
somatodendritic Hrs puncta compared to vehicle control (Figure 13A-B,D). This effect was 
replicated by an inactivating mutation of the Hrs FYVE domain (R183A; (Raiborg et al. 2001)) 
(Figure 13C-D), indicating that the FYVE/PI3P interaction is critical for membrane targeting of 
Hrs in neurons. However, 2 h treatment with SAR405 did not alter the number or motility of 
axonal Hrs puncta (Figure 13E-I), suggesting that Hrs association with vesicles occurs in the 
somatodendritic compartment prior to axonal transport, and remains stable in axons over the 




 Although studies in yeast and other eukaryotic cells have firmly established the presence 
of ESCRT-0 proteins on early endosomes (Sun et al. 2003; Raiborg, Rusten, and Stenmark 2003; 
Flores-Rodriguez et al. 2015; Raiborg et al. 2001; Henne, Buchkovich, and Emr 2011), the 
localization of ESCRT-0 proteins in axons have never been described. Moreover, it is well 
known that neurons contain a multitude of distinct endosomal subtypes not seen in other cells, 
which are often localized to a specific subcellular compartment (Yap et al. 2018; Maday and 
Holzbaur 2016; Kulkarni and Maday 2018b, 2018a). To better understand the function and 
regulation of the ESCRT pathway in neurons, we investigated the axonal pool of ESCRT-0 
structures.  Our findings suggest that axonal Hrs+ vesicles are a subset of total Rab5+ vesicles, 
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representing by our count ~40-60% of the total pool of axonal Rab5+ structures (Figure 11C,F). 
These ‘pro-degradative’ vesicles are likely distinct from other subsets of Rab5 endosomes 
previously identified (Olenick, Dominguez, and Holzbaur 2018; Goto-Silva et al. 2019), and 
based on our data (Figures 10&11) it seems that only this subset of axonal Rab5 vesicles is 
sensitive to neuronal activity. We hypothesize that these Hrs+/Rab5+ structures represent either 
early endosomes destined to become MVBs via later ESCRT protein recruitment, or transport 
vesicles bringing degradative machinery to the presynapse. Future studies will further explore 
these possibilities. 
 It is also remarkable that while the FYVE domain clearly regulates Hrs association with 
membranes (Figure 13), it does not regulate the activity-induced motility of Hrs in axons 
(Figures 7&12), suggesting that other domains are responsible for Hrs interaction with motor 
proteins. Moreover, unlike somatodendritic Hrs, axonal Hrs does not dissociate from vesicles 
within a 2-hour timeframe in response to a reduction in PI3P levels (Figure 13E-I). These 
findings provide the first indication that the vesicle association of the axonal pool of Hrs is 
different from that of the somatodendritic pool. The mostly likely interpretation of these data is 
that Hrs is assembled onto vesicles before their transport into axons, and that Hrs association 
with membranes in axons is more stable than that in the somatodendritic compartment. The 
apparent stability of axonal Hrs on vesicle membranes also suggests that these structures are not 
formed in response to neuronal activity, but rather that existing Hrs+ structures are mobilized by 
activity, as least in the 2 h time course that we examined. Future work will identify the factors 
that create this heightened stability. Overall, these data begin to elucidate the identity of axonal 
ESCRT-0 transport vesicles and brings us a step closer to understanding how the ESCRT 
pathway is dynamically regulated in neurons. 
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Chapters 3 and 4 demonstrate that ESCRT-0+ vesicles are more motile in response to 
neuronal activity and comprise a subset of Rab5-positive structures. Previous work from our lab 
shows that the ESCRT pathway mediates the activity-dependent degradation of SV proteins, and 
that neuronal firing increases the localization of ESCRT proteins to axons as well as their 
colocalization with SV pools (Sheehan et al. 2016). Thus, we hypothesized that an increase in 
neuronal activity would stimulate the recruitment of ESCRT-0+ vesicles to presynaptic boutons. 
To test this, we studied the colocalization of motile Hrs puncta with synaptic vesicle markers, in 
order to assess whether moving Hrs endosomes could be seen ‘pausing’ at presynaptic sites. We 
found that such pausing does occur, but its duration is not influenced by neuronal activity. Since 
we identified Hrs+ structures as a subset of Rab5+ vesicles, we next assessed whether these 
structures exhibited typical endosomal morphology, and whether neuronal firing causes an 
increase in the number of endosomal structures within presynaptic boutons. We find that Hrs+ 
structures in axons appear to be degradative endosomes, and that there are more endosomes and 




Figure 14. Motile Hrs interacts with presynaptic sites in a ubiquitin-dependent mechanism. (A) 
Representative images and corresponding kymographs for hippocampal axons expressing RFP-Hrs and 
EGFP-Synapsin. Arrows show Hrs+ puncta that colocalize with Synapsin. Scale bar, 10 µm. All scatter 
plots show mean ± SEM. (B) Immunoblot of lysates from HEK-293 cells transfected with VAMP2 and 
treated for 2 h with DMSO or deubiquitinating enzyme inhibitor PR619, then immunoprecipitated (IP) 
with VAMP2 antibody and probed with ubiquitin antibodies. Note that PR619 increases VAMP2 
ubiquitination. (C) Percentage of time that motile Hrs puncta are colocalized with Synapsin puncta 
during the 4 min imaging session, which does not change across conditions (P>0.05, one-way ANOVA 
with Dunnett's multiple comparisons test; ≥3 separate experiments, n=18 (control), 28 (acute Bic/4AP), 
28 (2 h Bic/4AP) videos/condition). (D) Percentage of time that that motile Hrs puncta colocalize with 
Synapsin puncta after treatment with Bic/4AP +/- PR619 for 2 h, showing a significant increase in the 
presence of PR619 (*P<0.05, unpaired t-test; ≥3 separate experiments, n=19 (Bic/4AP), 7 








Motile Hrs puncta colocalize with stationary Synapsin puncta in the axon 
 
Like other early endosome-associated proteins (e.g. Rab5) (Goto-Silva et al. 2019), Hrs 
exhibits a mixture of anterograde, retrograde, and bidirectional movement in axons (Figure 7F). 
However, treatment with Bic/4AP increases only the anterograde and bidirectional motility of 
Hrs (Figure 7F), signifying that neuronal activity preferentially increases Hrs transport towards 
more distal presynaptic terminals. To investigate whether this mobilization leads to increased 
Hrs contact with SV pools, we co-transfected dissociated hippocampal neurons with RFP-Hrs 
and EGFP-Synapsin (to label SV pools/presynaptic boutons (Leal-Ortiz et al. 2008)), and 
performed live imaging to assess colocalization between motile Hrs and stationary Synapsin 
puncta in axons. While we did observe motile Hrs puncta colocalizing with Synapsin at 
presynaptic sites (Figure 14A), this behavior did not depend upon neuronal activity, as motile 
Hrs puncta spent ~35% of their time in contact with Synapsin regardless of activity condition 
(Figure 14C). However, Hrs/Synapsin colocalization was significantly increased following 2 h of 
treatment with PR619 (Figure 14C), a deubiquitinating enzyme inhibitor that promotes SV 
protein ubiquitination (Figure 14B), suggesting that Hrs interaction with presynaptic sites is 
ubiquitin-dependent. This finding is consistent with the role of Hrs in binding ubiquitinated 
proteins and sorting them toward MVBs.  
 
CLEM reveals that axonal Hrs-positive vesicles are degradative structures 
 
To examine the morphology of Hrs-positive vesicles in axons and at presynaptic boutons, 
we performed correlative-light electron microscopy on cultured neurons lentivirally co-
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transduced with vesicular glutamate transporter (vGlut1-GFP) to label SV pools and HaloTag-
Hrs. Interestingly, Hrs-positive structures identified in the axon appear to be degradative in 
nature, including an endosome and a multivesicular body (Figure 15A). These data, along with 
our previous findings (Sheehan et al. 2016), suggest that Hrs is associated with degradative 
structures in axons.  
 
Figure 15. Correlative light electron microscopy (CLEM) reveals that Hrs+ vesicles can be 
degradative structures. (A) Representative CLEM images of axons from hippocampal neurons 
transduced with vGlut1-EGFP (green) and Halo-Hrs (+ Jenelia-Halo-549 nm; red), treated for 2 h with 
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Bic/4AP. Each set of images has a lower magnification image of the putative axon, and a higher 
magnification image of the Halo-Hrs-positive structure (white arrows). 
 
Endosomal structures are more prevalent at the synapse in high-activity conditions 
 
In our earlier study, we demonstrated that neuronal firing increases the recruitment of 
ESCRT proteins into axons and their colocalization with SV markers (Sheehan et al. 2016). 
Given the role of ESCRT proteins in catalyzing MVB formation (Raiborg, Rusten, and Stenmark 
2003), these changes in ESCRT protein localization may increase numbers of MVBs and other 
endosomal structures at presynaptic boutons. We therefore examined electron micrographs of 
boutons from 16-21 DIV hippocampal neurons treated for 48 h with tetrodotoxin (TTX) to 
reduce neuronal firing or Gabazine to increase firing. We observed a significantly higher density 
of presynaptic MVBs and endosomes (defined as single-membrane structures >80 nm in 
diameter) following gabazine versus TTX treatment (Figure 16A,C), suggesting that neuronal 
activity promotes the appearance of these structures at presynaptic boutons. Since other studies 
have reported that neuronal firing stimulates the biogenesis of autophagosomes at presynaptic 
terminals (T. Wang et al. 2015), we also counted the number of multilamellar structures present 
under each condition. Interestingly, not only was the average density of these structures lower 
than that of endosomes/MVBs regardless of activity level (~0.1 multilamellar structures/m2 vs. 
~1 endosomes/m2 at baseline), but we also did not see an increase with Gabazine treatment 
(Figure 16B,D), indicating that prolonged neuronal activity specifically increases the number of 




Figure 16. Neuronal activity increases the number of presynaptic endosomes. (A-B) 
Representative electron micrographs of endosomal structures (single-membrane, >80nm diameter, red 
arrows; A) and multilamellar structures (>1 membrane, red arrows; B) present at presynaptic boutons 
from 16-21 DIV hippocampal neurons treated for 48 h with TTX or gabazine. Scale bar, 500 nm. (C-
D) Quantification of endosomal structures (C) and multilamellar structures (D) per µm2 of presynaptic 
area at TTX- or gabazine-treated boutons. The density of endosomal structures, but not multilamellar 
structures, is significantly increased following gabazine treatment. Scatter plot shows median and 






The role of the endolysosomal pathway in degrading specific SV proteins (Sheehan et al. 
2016; Uytterhoeven et al. 2011, 2017), in concert with the findings that ESCRT proteins are 
more motile in the anterograde direction (Figure 7) and exhibit increased colocalization with 
presynaptic markers after prolonged neuronal firing (Sheehan et al. 2016), strongly suggest that 
ESCRT-0 proteins are recruited to the synapse by neuronal activity in order to degrade SV 
proteins. In this chapter, we provide more definitive evidence for this model, showing that motile 
Hrs+ vesicles spend ~35% of their time in contact with presynaptic markers, and that this 
percentage can be increased by enhancing protein ubiquitination. Neuronal activity also increases 
the number of anterogradely and bidirectionally motile Hrs puncta (Figure 7), thereby increasing 
the likelihood that Hrs vesicles interact with SV pools. We also analyzed the morphology of Hrs-
positive structures in axons and at presynapses using correlative light electron microscopy 
(CLEM). Although we could not obtain a large enough sample for statistical analysis, we found 
that axonal structures carrying Hrs exhibited morphological hallmarks of degradative endosomes 
and MVBs (Figure 15A). Finally, we determined statistically that neuronal activity increases the 
number of endosomes within presynaptic boutons (Figure 16A,C), providing evidence that 
neuronal activity increases the formation and/or delivery of endosomes to presynapses. 
Altogether, these data support the hypothesis that ESCRT-0 endosomes are transported to SV 
pools in response to neuronal activity, in order to initiate the degradation of synaptic vesicle 
proteins. Future experiments will yield further insights into the regulation of the endolysosomal 




Chapter 6: KIF13A is responsible for activity-dependent anterograde 
movement of Hrs in the axon, and necessary for the turnover of ESCRT-




We have shown that axonal Hrs+ puncta exhibit pronounced changes in directional 
motility following 2 h Bic/4AP treatment, in particular a >2-fold increase in anterograde 
transport (Figure 7F). These findings suggest that a plus-end directed kinesin motor protein 
mediates at least some element of the activity-dependent transport of Hrs. Multiple kinesins have 
been implicated in the axonal transport of various cargo (Jenkins et al. 2012; Bentley et al. 2015; 
Maday et al. 2014), creating a panoply of potential candidates. However,  previous studies have 
identified kinesins specifically responsible for the plus-end directed transport of Rab5+ early 
endosomes, including the kinesin-3 family members KIF13A and KIF13B (Bentley et al., 2015, 
Journal of Cell Biology; Huckaba et al., 2011, Journal of Biological Chemistry). Since Hrs+ 
axonal puncta are a subset of Rab5 structures (Figure 11B,E), this provided a convenient starting 
point, and we investigated the possibility that KIF13A/B are involved in the axonal transport of 
Hrs+ endosomes. Using a split kinesin assay (Bentley and Banker 2015), we found that KIF13A, 
but not KIF13B, interacts with Hrs+ endosomes. We next evaluated the importance of this motor 
for activity-dependent ESCRT-0 motility, as well as for SV protein degradation. These studies 
revealed that knockdown of endogenous KIF13A in cultured neurons ablates the activity-induced 
increase in ESCRT-0 puncta motility and slows the degradation of SV proteins. Overall, these 
results suggest that the transport of ESCRT-0+ endosomes by KIF13A is vital to the neuronal 




Figure 17. KIF13A and KIF13B mediate transport of Rab5+ vesicles in N2a cells. (A-B) 
Representative images of N2a cells transfected with BicD2-GFP-FKBP (green) and KIF13A-FRB-Myc 
(blue; A) or KIF13B-FRB-Myc (blue; B), +/- rapamycin analogue to link FKBP/FRB (linker). (C-D) 
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Representative images of N2a cells transfected with mCh-Rab5 (red), BicD2-GFP-FKBP (green), and 
KIF13A-FRB-Myc (blue), +/- linker, and corresponding line scan graphs. White arrows show line scan 
area. (D) showing that addition of linker induces protein colocalization. (E-F) Representative images of 
N2a cells transfected with mCh-Rab5 (red), BicD2-GFP-FKBP (green), and KIF13B-FRB-Myc (blue), 
+/- linker, and corresponding line scan graphs. White arrows show line scan area. (F) showing that 




KIF13A, but not KIF13B, interacts with Hrs+ vesicles 
 
Previous work provided us with two strong candidates for the plus-end directed transport 
of ESCRT-0+ vesicles: kinesin-3 motors KIF13A and KIF13B (Bentley et al., 2015, Journal of 
Cell Biology; Huckaba et al., 2011, Journal of Biological Chemistry). Using an assay developed 
to evaluate the ability of specific kinesins to transport particular cargoes (Bentley and Banker 
2015), which had been previously used to confirm that these motors facilitate Rab5 motility, we 
examined whether KIF13A and/or KIF13B mediate the transport of Hrs. We first confirmed the 
efficacy of this assay in Neuro2a (N2a) cells, as previous work had been done in fibroblasts 
(Bentley et al. 2015), by transfecting cells with the minus-end directed motor domain of BicD2 
(BicD2-GFP-FKBP), together with the cargo binding domain of KIF13A or KIF13B (KIF13A-
FRB-Myc, KIF13B-FRB-Myc). As previously reported, addition of a membrane-permeant 
rapamycin analog to link the FRB and FKBP domains led to the cotransport of BicD2 and 
KIF13A/B to the cell centrosome (Figure 17A-B). Moreover, we were able to recapitulate 
transport of Rab5 by both KIF13A and KIF13B as previously observed (Figure 17C-F (Bentley 
et al. 2015)). We next tested the ability of KIF13A and KIF13B to facilitate transport of RFP-
Hrs. Surprisingly, while Hrs was readily transported to the centrosome in the presence of the 
linker and KIF13A (Figure 18A-B), it was not transported by KIF13B (Figure 18C-D). These 
findings indicate a specificity of the transport mechanism for Hrs+ vesicles that does not exist for 
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all Rab5+ vesicles. We further tested the specificity of interactions between Hrs and KIF13A/B 
by coimmunoprecipitation in N2a cells co-transfected with RFP-Hrs, STAM1-mCh, or mCherry 
control, together with the KIF13A- or KIF13B-FRB-Myc constructs. Consistent with our 
transport assays, we found that Hrs clearly precipitated KIF13A, but not KIF13B (Figure 18E-F). 
STAM1 also had some ability to precipitate KIF13A, albeit variably, but did not precipitate 
KIF13B (Figure 18E-F). We repeated this coimmunoprecipitation assay in the presence of high 
K+ stimulation (50 mM KCl for 2 h; (La Montanara et al., 2015)) to depolarize the N2a cells, and 
preliminary results indicated that Hrs precipitates more KIF13A after 2 h of stimulation. These 
data suggest that the Hrs/KIF13A interaction may grow stronger in a depolarized environment 
(Figure 19A-B), however more work must be done to validate this finding. Overall, these results 
suggest that Hrs, and potentially STAM1, interact with KIF13A, and identify this motor protein 




Figure 18. KIF13A, but not KIF13B, mediates transport of Hrs+ vesicles. (A) Representative 
images of N2a cells co-transfected with RFP-Hrs (red), BicD2-GFP-FKBP (green), and KIF13A-FRB-
Myc (blue), +/- rapamycin analogue to link FKBP/FRB (linker). (B) Line scan graphs of the images in 
panel A, showing that addition of the linker induces colocalization of these proteins as depicted by a 
single peak in the lower graph. White arrows show line scan area. (C-D) Representative images of N2a 
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cells co-transfected with RFP-Hrs (red), BicD2-GFP-FKBP (green), and KIF13B-FRB-Myc (blue), +/- 
linker (C), and corresponding line scan graphs (D) showing that addition of linker does not induce 
protein colocalization. (E) Immunoblot of lysates from N2a cells expressing mCh, mCh-STAM, or 
RFP-Hrs, together with KIF13A-FRB-Myc or KIF13B-FRB-Myc, immunoprecipitated (IP) with mCh 
antibody and probed with Myc or mCh antibodies. (F) Quantitative analysis of KIF13A/B-FRB-Myc 
band intensity after immunoprecipitation with Hrs or STAM, expressed as intensity normalized to mCh 
control. Hrs consistently precipitates KIF13A but not KIF13B (**P<0.001, one-way ANOVA with 
Dunnett's multiple comparisons test; ≥3 separate experiments). Bars show mean ± SEM. 
 
 
Figure 19. Depolarization increases the association between KIF13A and Hrs. (A) Immunoblot of 
lysates from N2a cells expressing mCh, mCh-STAM, or RFP-Hrs, together with KIF13A-FRB-Myc, 
treated either with 50 mM KCl (high K+) or 2.5 mM KCl (control) for 2 h, then immunoprecipitated 
(IP) with mCh antibody and probed with Myc or mCh antibodies. (B) Quantitative analysis of KIF13A-
FRB-Myc band intensity after immunoprecipitation with Hrs or STAM, expressed as intensity 
normalized to mCh control. Hrs precipitates KIF13A more after high K+ treatment. Results are 
preliminary and represent only 1 week of replicates. 
 
Knockdown of KIF13A ablates activity-dependent increase in ESCRT-0 motility and slows 
degradation of SV proteins 
 
To test whether KIF13A is necessary for the transport of ESCRT-0 vesicles in neurons, 
we next examined the effects of KIF13A knockdown on ESCRT-0 protein axonal transport and 
function. For these studies, we used an shRNA against rat KIF13A (sh13A) that produced a 
~60% knockdown of the protein after lentiviral transduction (transduced 7 DIV, harvested 14 
DIV; Figure 20A-B). Our previous work showed that a direct Hrs knockdown inhibits the 
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degradation of several SV membrane proteins, including Synaptic Vesicle protein 2 (SV2) and 
Vesicle-associated membrane protein 2 (VAMP2)(Sheehan et al. 2016). We therefore reasoned 
that knockdown of KIF13A should similarly impair the degradation of these SV proteins if it is 
required for anterograde axonal transport of Hrs. To test this, we used our previously described 
cycloheximide-chase assay (Sheehan et al. 2016) to measure the degradation of SV2 and 
VAMP2 in neurons expressing sh13A or a scrambled control shRNA (shCtrl). We found that 
degradation of both SV2 and VAMP2 was reduced in the presence of sh13A compared to shCtrl 
(Figure 21A-C), suggesting that KIF13A is necessary to the timely breakdown of these SV 
proteins. To directly examine the effects of KIF13A knockdown on the axonal motility of Hrs, 
we co-expressed EGFP-Hrs together with sh13A or shCtrl in neurons cultured in microfluidic 
chambers as previously described. Time-lapse imaging revealed that sh13A expression did not 
alter either the motility (Figure 20C), directional movement (Figure 20C), or speed (Figure 20D) 
of Hrs under control conditions compared to shCtrl. However, this hairpin completely abolished 
the activity-dependent increase in Hrs motility (Figure 22A,C,E). Similar effects were seen for 
STAM1, as baseline puncta motility was unaffected by sh13A, while activity-dependent motility 
was inhibited (Figure 22B,D,F). Overall, these data indicate that KIF13A is responsible for the 
activity-dependent transport of ESCRT-0+ vesicles in axons and is necessary for the degradation 




Figure 20. Knockdown of KIF13A by sh13A expression in neurons. (A) Representative 
immunoblot of lysates of 13-15 DIV hippocampal neurons transduced with sh13A or scrambled 
shRNA control (shCtrl) on 7 DIV, probed with antibodies against KIF13A and tubulin. (B) 
Quantification of KIF13A band intensity, normalized to tubulin control, with shCtrl or sh13A 
expression (**P<0.01, unpaired t-test; ≥3 separate experiments). Bars show mean ± SEM. (C) 
Breakdown of directional movement of Hrs puncta under control conditions, expressed as percentage 
of total Hrs puncta, with shCtrl or sh13A expression. Knockdown of KIF13A does not alter baseline 





These results strongly implicate the kinesin-3 motor KIF13A in the activity-dependent 
anterograde motility of ESCRT-0. The finding that knockdown of KIF13A slows SV protein 
degradation (Figure 21A-C) also suggests that this activity-dependent motility may be at play, 
undetectably to our methods, even in the lower-activity baseline condition of our cultured 
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neurons. This and many other unknowns, including the identities of the motors and adaptors 
involved in non-activity-dependent ESCRT-0 motility, comprise significant questions to be 
addressed in future work. However, these data reveal a vital link between the activity-dependent 
increase in motility that we find is specific to ESCRT-0, and the degradation of SV proteins, the 
manifest function of the ESCRT pathway in neurons. These results furthermore ideate KIF13A 
as a vital actor in the maintenance of synaptic proteostasis, and therefore a potentially crucial 
pillar of long-term neuronal health. However, a more complete picture of the mechanism by 
which activity regulates the interaction between KIF13A and ESCRT-0 will be necessary to fully 
substantiate these findings. Overall, this work represents the first identification of a kinesin 
motor protein essential to the activity-dependent motility of the newly described specialized 
ESCRT-0+/Rab5+ endosomes. Future work will continue to characterize the function of these 
structures, their interaction with synapses, and the regulation of their motility – activity-
dependent and otherwise.  
 
Figure 21. Knockdown of KIF13A slows SV protein degradation. (A) Representative immunoblots 
of SV2 and VAMP2, with corresponding tubulin loading controls, from lysates of 14 DIV hippocampal 
neurons transduced with shCtrl or sh13A to knockdown KIF13A and treated for 24 h with DMSO 
control (CON) or cycloheximide (CHX). (B-C) Quantification of the fold-change in SV2 (C) and 
VAMP2 (D) degradation under these conditions, calculated as previously described (Sheehan et al. 
2016). Degradation of both proteins is significantly decreased in the presence of sh13A (*P<0.05, 





Figure 22. Knockdown of KIF13A inhibits activity-dependent transport of ESCRT-0 proteins. 
(A) Representative images and corresponding kymographs of microfluidically isolated hippocampal 
axons transduced with EGFP-Hrs and shCtrl under control conditions (upper panels) and after 2 h 
treatment with Bic/4AP (lower panels). Scale bar, 10 µm. (B) Representative images and 
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corresponding kymographs of microfluidically isolated hippocampal axons expressing STAM1-mCh 
and shCtrl under control conditions (upper panels) and after 2 h treatment with Bic/4AP (lower panels). 
Scale bar, 10 µm. (C) Representative images and corresponding kymographs of microfluidically 
isolated hippocampal axons expressing EGFP-Hrs and sh13A under control conditions (upper panels) 
and after 2 h treatment with Bic/4AP (lower panels). Scale bar, 10 µm. (D) Representative images and 
corresponding kymographs of microfluidically isolated hippocampal axons expressing STAM1-mCh 
and sh13A under control conditions (upper panels) and after 2 h treatment with Bic/4AP (lower 
panels). Scale bar, 10 µm. (E) Percentage of motile Hrs puncta in axons, showing that the increased 
motility of Hrs after 2 h Bic/4AP treatment is abolished in sh13A-expressing neurons (***P<0.001, 
one-way ANOVA with Sidak’s multiple comparisons test; ≥3 separate experiments, n=14 
(shCtrl+control), 16 (shCtrl+2 h Bic/4AP), 16 (sh13A+control), 15 (sh13A+2 h Bic/4AP) 
videos/condition). (F) Percentage of motile STAM1 puncta in axons, showing that the increased 
motility of STAM1 after 2 h Bic/4AP treatment is abolished in sh13A-expressing neurons 
(***P<0.001, one-way ANOVA with Sidak’s multiple comparisons test;  ≥3 separate experiments, 
n=14 (shCtrl+control), 15 (shCtrl+2 h Bic/4AP), 13 (sh13A+control), 13 (sh13A+2 h Bic/4AP) 



















Chapter 7: Discussion and Future Directions 
 
In this study, we demonstrate a novel mechanism for spatiotemporal regulation of the 
ESCRT pathway in neurons. Our findings show that axonal vesicles carrying ESCRT-0 proteins 
exhibit increased anterograde and bidirectional motility in response to neuronal firing (Figures 
7&23), providing the first example of activity-dependent transport of degradative machinery in 
axons. Previous investigations have reported that both the axonal motility of mitochondria and 
the inter-bouton transport of SVs are regulated by neuronal activity in hippocampal neurons, 
specifically by presynaptic calcium influx (M.-Y. Lin and Sheng 2015; Chen and Sheng 2013; 
Gramlich and Klyachko 2017; Qu et al. 2019). These processes are hypothesized to contribute to 
the activity-dependent remodeling of synapses in order to alter neurotransmitter release 
properties, and to ensure that highly active synapses are properly replenished (Gramlich & 
Klyachko, 2017; Lin & Sheng, 2015). Synaptic activity has also been shown to induce the 
postsynaptic recruitment of proteasomes and lysosomes in cultured neurons, as well as the local 
biogenesis of autophagosomes at pre- and postsynaptic sites (T. Wang et al. 2015; Bingol and 
Schuman 2006; Goo et al. 2017; Shehata et al. 2012; Soukup et al. 2016; Vanhauwaert et al. 
2017; Kulkarni and Maday 2018a). However, the axonal transport of autophagosomes in cultured 
neurons appears to be a constitutive process that is unaffected by stimuli such as synaptic activity 
and glucose levels (Maday and Holzbaur 2016; Maday, Wallace, and Holzbaur 2012). Axonal 
autophagosomes, once formed at the presynapse, undergo reliable retrograde trafficking to the 
soma while acidifying into autolysosomes (Maday and Holzbaur 2016; Maday, Wallace, and 
Holzbaur 2012). In contrast, we find that axonal transport of ESCRT-0 proteins Hrs and STAM1 
is bidirectional and sensitive to neuronal activity levels. We hypothesize that these characteristics 
facilitate increased contact of this early ESCRT machinery with SV pools, thereby catalyzing the 
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activity-dependent degradation of SV proteins. This regulation by neuronal firing is undoubtedly 
mediated by a consequence of an action potential traveling along an axon and invading a bouton, 
i.e. calcium influx, rather than by neurotransmission itself. Calcium chelators could be used in 
the presence of bicuculline/4AP to test whether calcium mediates the activity-dependent changes 
to ESCRT motility, as is the case for mitochondrial and SV motility. One could also test whether 
pharmacologically inducing an influx of extracellular calcium or an efflux of stored calcium 
from the endoplasmic reticulum induces ESCRT motility. If this motility is calcium-dependent, it 
should next be determined whether calcium stimulates, or is necessary for, the interaction 
between ESCRT-0 and KIF13A, as described in detail below.  
 
Figure 23. Model of how activity stimulates the anterograde transport of ESCRT-0+ vesicles. We 
hypothesize that an increase in intra-axonal Ca2+ due to neuronal firing stimulates the association of 
axonal ESCRT-0-positive vesicles with plus-end directed kinesin KIF13A. Over time, this leads to an 
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increase in anterograde transport of these vesicles, which deliver Hrs and STAM1 to SV pools in order 
to mediate the activity-dependent degradation of SV proteins.  
 
 
Autophagy and the ESCRT pathway 
 
 My work shows that the axonal motility patterns of specific ESCRT-0 and -I proteins 
differ significantly from that of autophagosome marker LC3. However, the complex and 
interdependent relationship between autophagy and the ESCRT pathway precludes the 
conclusion that these pathways are therefore uncoupled in the axon. It is clear from the literature 
that autophagy is dysregulated in the absence of functional ESCRT, particularly ECRT-III 
proteins (J.-A. Lee et al. 2007; Tor Erik Rusten and Simonsen 2008). These observations have 
kindled several theories about the possible function of the ESCRT pathway in autophagy 
induction, closure of the phagophore, and/or fusion with the late endosome/lysosome (T E 
Rusten and Stenmark 2009).  In axons, Cheng et. al. found that autophagosomes must fuse with 
late endosomes in order to acquire enough dynein to begin their retrograde journey to the soma 
(Cheng et al. 2015). Moreover, it has been shown repeatedly that axonal autophagosomes form 
in growth cones or at presynaptic boutons (Maday, Wallace, and Holzbaur 2012; T. Wang et al. 
2015; Maday et al. 2014), obviating their need to travel in the anterograde direction to interact 
with synaptic cargoes. These findings, in concert with our conclusion that ESCRT membrane 
assemblies are likely formed in the soma, suggest that ESCRT proteins may show a more 
complex directional profile than autophagosome markers simply because they must travel both to 
and from the synapse. Moreover, given the frequent and potentially necessary fusion of late 
endosomes with autophagosomes, there is a strong possibility that retrogradely-moving axonal 
ESCRT+ vesicles are amphisomes or precursors to autolysosomes. To test this, neurons co-
transfected with ESCRT proteins and LC3 could be subjected to live axonal imaging, and the 
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directional breakdown of these co-positive structures compared to those of individual ESCRT 
proteins and LC3 alone. It is possible that ESCRT proteins associated with late endosomes, 
particularly ESCRT-III, will show a stronger colocalization with autophagosome markers and 
more retrograde motility. Moreover, additional correlative light electron microscopy (CLEM) 
experiments with ESCRT-I, -II, and -III proteins should be performed to determine whether any 
ESCRT+ structures exhibit morphological hallmarks of amphisomes. These experiments will 
elucidate the relationship between ESCRTs and autophagosomes in the axon.  
 
Specificity of Activity-Dependent Regulation to ESCRT-0+ Vesicles 
 
 Although there are multiple ESCRT components, their roles are highly interconnected, as 
illustrated by the fact that mutation of a single ESCRT protein is enough to thoroughly damage 
endolysosomal processing and induce neurodegeneration (D. Lee et al. 2019; J. A. Lee et al. 
2007; Y. Zhang et al. 2017; Muzioł et al. 2006). It is evident from the literature that ESCRT 
function relies on the coordinated recruitment of all the ESCRT complexes to the same 
microdomain on the endosomal membrane (Henne, Buchkovich, and Emr 2011; Hurley 2015). 
Moreover, our previous study indicated that both ESCRT-0 component Hrs and ESCRT-III 
component CHMP2B are recruited to presynaptic sites in response to prolonged neuronal firing 
(24 h Bic/4AP; (Sheehan et al. 2016)). In light of these findings, it is interesting that the 
regulation of ESCRT-0 transport by neuronal activity does not appear to extend to the ESCRT-I 
complex (Figures 7&8). However, an analysis of the unique role played by ESCRT-0 in overall 
ESCRT function suggests why this may be the case. First, of all the ESCRT complexes, ESCRT-
0 alone is capable of stable, independent membrane association. This feature makes it easier for 
us to characterize the axonal motility of ESCRT-0 proteins in our overexpression system and 
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provides a potential explanation as to why the regulation of ESCRT-0 axonal transport by 
activity appears more robust than for downstream ESCRT complexes. It is possible that 
regulation of axonal transport vesicles carrying ESCRT-0 is sufficient for localization of the 
entire pathway, if ESCRT-0 can initiate recruitment of the rest of the pathway. This concept 
underlies the second reason why the ESCRT-0 complex alone may be regulated by activity.  
While downstream ESCRT complexes interact mainly with each other and fleetingly with the 
membrane, ESCRT-0 shows the strongest interaction with ubiquitin, and thus with nascent 
ESCRT-0 cargo. This property is consistent with our finding that Hrs interacts with SV proteins 
for longer time periods in the presence of a DUB inhibitor to boost ubiquitination (Figure 
14B,D), and suggests that the ESCRT-0 complex alone has the ability to ‘discover’ and interact 
with cargoes. Altogether, this leads us to hypothesize that ESCRT-0 vesicles are the ‘first 
responders’ of the ESCRT pathway, and therefore the most sensitive to regulatory stimuli. In this 
case, the targeting of ESCRT-0 proteins to presynaptic sites, perhaps via an interaction with 
ubiquitinated synaptic vesicle cargo, is sufficient to localize and activate the rest of the ESCRT 
pathway. This concept must be tested by characterizing the motility and synaptic localization of 
downstream ESCRT pathway components in the presence or absence of Hrs and activity. The 
‘first-responder’ theory will be bolstered if Hrs knockdown impedes both ESCRT pathway 
function (as previously shown; (Sheehan et al. 2016)) and the synaptic localization of later 
ESCRT proteins. If our hypothesis is borne out by these experiments, the next question to 
address is how downstream ESCRT complexes are localized to the sites ‘chosen’ by ESCRT-0. 
Are vesicles carrying ESCRT-I, -II, and -III proteins directed to presynaptic sites by activity, but 
in a time course outside the scope of this study (2h of stimulation)? Or are such vesicles present 
diffusely throughout axons, and thus already available for recruitment wherever ESCRT-0 
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complexes go? These questions can be answered by mapping the localization and transport 
properties of ESCRT-I, -II, and -III components at different time points after treatment with 
Bic/4AP. These data will be vital to expanding our understanding of ESCRT pathway function 
and regulation in neurons.  
 
Identity of ESCRT-0+ Vesicles 
 
 Our data indicate that axonal ESCRT-0+ vesicles represent a specialized endosomal 
subtype. Endosomes are highly dynamic and heterogenous structures in all cells, and particularly 
in neurons, whose complex morphology and high protein trafficking demands have given rise to 
multiple distinct classes of endosomes that are spatially restricted within different neuronal 
compartments (Maday and Holzbaur 2016; Yap et al. 2018). Early endosomes are classically 
defined by the markers Rab5 and EEA1 (Langemeyer, Fröhlich, and Ungermann 2018; 
Simonsen et al. 1998; Gorvel et al. 1991); however, recent studies have identified sub-categories 
of early endosomes in neurons that can be differentiated both by their markers and axonal 
transport patterns (Olenick, Dominguez, and Holzbaur 2018; Leonard et al. 2008). The axonal 
ESCRT-0+ vesicles we describe represent a novel addition to this category. We find that while 
the total pool of axonal Rab5+ vesicles exhibits high motility under baseline conditions and a 
relatively modest activity-induced increase in anterograde motility (Figure 10F), the Hrs+ subset 
of this pool exhibits limited motility at baseline, but significant activity-induced anterograde and 
bidirectional motility (Figure 7F). Moreover, our CLEM experiments demonstrate that axonal 
Hrs+ vesicles can be degradative structures (Figure 15A), although we cannot yet correlate their 
morphology with their axonal transport history to determine what stage of the degradative 
process they represent. In future experiments, we will track activity-regulated Hrs+ vesicles over 
a longer time course to assess: 1) where these vesicles originate (i.e. in the soma or proximal 
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axon), 2) which motor proteins transport these vesicles, and how neuronal activity affects their 
vesicle association, and 3) how vesicle morphology correlates with transport history (e.g. do 
motile structures have a different morphology from stationary structures). This will require 
imaging axonal ESCRT-0+ vesicles over a longer period of time, as well as marking vesicles in 
fluidically isolated neurons in either the somatodendritic or axonal compartments, and 
determining their localization and morphology at different time points. These results will provide 
crucial insights into the regulation and identity of the activity-responsive Hrs vesicles 
characterized here. Moreover, STAM1 is also is a member of the ESCRT-0 complex. We did not 
assess STAM1 vesicle morphology or colocalization with Rab5 in this study, but we have 
previously observed that co-expressed Hrs and STAM1 are highly colocalized in axons, as the 
literature predicts (Mayers et al. 2011; Ren and Hurley 2010), and we find here that STAM1+ 
vesicles exhibit very similar activity-dependent dynamics to Hrs+ vesicles (Figure 7). This 
unique sensitivity of ESCRT-0+ vesicles to neuronal activity, together with their morphological 
characteristics and ubiquitin-dependent colocalization with SV pools (Figure 14B,D), suggests 
that they have a specific function: mediating the activity-dependent degradation of old and/or 
dysfunctional SV proteins. This hypothesis aligns with previous research indicating that SV 
proteins become increasingly dysfunctional as they age and undergo multiple cycles of 
exo/endocytosis (Truckenbrodt et al. 2018; Fernandes et al. 2014). This theory can be further 
tested by using fixed and live-cell imaging to assess the relative colocalization of ESCRT-0 with 
SV proteins of different ages (as determined in (Truckenbrodt et al. 2018)), as well as whether 
the pausing of ESCRT-0 at presynapses is affected by the proportion of older vesicles. We 
hypothesize that older synaptic vesicle proteins, which have had longer to accumulate molecular 
damage, are more likely to be ubiquitinated, and thus more likely to attract ESCRT-0. Our work 
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lays out the possibility that the neuronal ESCRT pathway is designed to deal with this issue of 
aged and dysfunctional SV proteins and is activated by high neuronal firing in order to protect 
synaptic function.  
 
Hrs Endosomal Targeting  
 
 In addition to characterizing the dynamic behavior and morphology of ESCRT-0 axonal 
transport vesicles, this study investigates the mechanisms of Hrs targeting to these vesicles. As in 
non-neuronal cells (Gaullier et al., 2000; Komada & Soriano, 1999), we find that the association 
of Hrs with vesicles is dependent upon interactions between its FYVE domain and the 
endosomal lipid PI3P (Figure 13). Blocking PI3P synthesis with a VPS34 inhibitor (SAR405) or 
expressing a FYVE domain-inactivating mutant form of Hrs, leads to a significant loss of Hrs 
membrane targeting in the somatodendritic compartment (Figure 13A-D). However, treatment 
with SAR405 does not alter the number, speed, or motility of Hrs puncta in axons (Figure 13E-
I). Together, these findings indicate that the axonal pool of Hrs-positive vesicles is assembled in 
the somatodendritic compartment, and that Hrs interactions with axonal transport vesicles are 
stable for at least 2 hours. A potential alternative explanation for this finding is that a different 
domain of Hrs mediates its association with axonal vesicles. Indeed, it was previously reported 
that the FYVE domain is insufficient for Hrs membrane targeting, as the C-terminal coiled-coil 
domain is also necessary for this function (Raiborg et al. 2001). Interestingly, the coiled-coil 
domain of Hrs is known to interact with SNAP-25 (Kwong et al. 2000), a SV-associated protein 
and component of the SNARE complex required for SV fusion (McMahon & Südhof, 1995; 
Söllner et al., 1993). Given that SNAP-25 must also be transported to presynaptic terminals, it is 
conceivable that its presence on axonal transport vesicles is required for the recruitment and/or 
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stabilization of Hrs on these structures. This can be assessed by determining via imaging whether 
SNAP-25 is present on ESCRT-0+ vesicles, and if so whether its knockdown or mutation alters 
the stability of Hrs on endosomal membranes. It is also interesting to note that EEA1, which 
targets to early endosome membranes via its FYVE domain, does not localize to axons (Gaullier 
et al., 2000; Lawe et al., 2000; Wilson et al., 2000), indicating that additional domains and 
protein interactions may be required for axonal targeting of FYVE domain-containing proteins. 
These domains could be identified by selectively mutating Hrs and assessing membrane 
localization of the mutants in both the somatodendritic and axonal compartments. This work will 
continue to define the interactions that direct axonal Hrs to vesicular membranes, and such 
findings will likely inform our understanding of the axonal targeting of other proteins. 
Interestingly, recent studies have uncovered the prominent role that the axon initial segment 
(AIS) plays in maintaining separation between axonal and somatodendritic pools of vesicles 
(Kulkarni and Maday 2018a; Song et al. 2009). It would be fascinating to address whether this 
physical barrier plays a role in regulating the axonal transport of ESCRT proteins, and whether it 
is influenced by activity. This could be done by assessing ESCRT subcellular localization in the 
presence of a knockdown or mutation of a crucial AIS protein such as Ankrin-G, and by 
determining via imaging whether there are any changes to how ESCRT proteins interact with the 
AIS in the presence of high neuronal activity. 
 
Activity-Dependent Transport of ESCRT-0+ Vesicles 
 
 Finally, our work has begun to elucidate the mechanisms of activity-dependent transport 
of ESCRT-0+ vesicles, in particular the role of kinesin-3 family member KIF13A in this process. 
Surprisingly, we find that although both KIF13A and KIF13B mediate transport of Rab5 in a 
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reconstituted transport assay (Figure 17C-F), as previously reported (Bentley et al., 2015), only 
KIF13A transports Hrs (Figure 18A-D). This specificity is confirmed by coimmunoprecipitation 
assays in which Hrs precipitates KIF13A to a much greater degree than KIF13B (Figure 18E-F), 
further bolstering the theory that ESCRT-0 vesicles comprise a specialized subset of pro-
degradative endosomes with unique transport properties. KIF13A and KIF13B are highly 
homologous proteins that share multiple cargoes, including early and recycling endosome 
associated proteins Rab5, Rab10, and transferrin receptor (Jenkins et al., 2012; Bentley et al., 
2015; Etoh & Fukuda, 2019). These kinesins also have distinct cargoes, including low density 
lipoprotein receptor (for KIF13B; Jenkins et al., 2012) and serotonin type 1a receptor (for 
KIF13A; Zhou et al., 2013), as well as Hrs and STAM1 (Figure 18E-F). It is possible that these 
distinct cargoes reflect differences in the subcellular localization of KIF13A and KIF13B in 
neurons. However, current reports about their localization are conflicting, with one study 
showing that KIF13A localizes to axonal and dendritic vesicles while KIF13B is primarily 
dendritic (Jenkins et al., 2012), and another showing that KIF13B has an axonal bias whereas 
KIF13A is exclusively dendritic (Yang et al., 2019). In our experiments, we find that knockdown 
of KIF13A prevents the activity-induced motility of Hrs and STAM1 in axons (Figure 22), 
indicating that KIF13A has an essential role in the axonal transport of these ESCRT-0 proteins. 
Our findings also highlight the importance of KIF13A-mediated transport in SV protein 
degradation, which is impaired by KIF13A knockdown under basal conditions (Figure 21). 
These data suggest that activity-dependent transport of ESCRT-0 proteins occurs even under 
conditions of lower neuronal firing but may be enveloped into what we identified as ‘baseline’ 
motility. As delineated above, additional experiments are needed to characterize the mechanism 
by which KIF13A facilitates the activity-dependent transport of Hrs, we well as its interaction 
 
 84 
with ESCRT-0 vesicles. The first experiment that should be conducted is live cell imaging of 
neurons co-transfected with Hrs and KIF13A to determine what percentage of axonal Hrs+ 
vesicles interact with KIF13A, how the presence or absence of KIF13A on an Hrs+ vesicle 
correlates to its motility pattern, and whether KIF13A is present on only activity-recruited Hrs+ 
vesicles. It is possible that activity increases the colocalization between Hrs and KIF13A, which 
can be tested by proximity ligation assay in neurons co-transfected with Hrs and KIF13A and 
treated with Bic/4AP. This would also reveal the sub-cellular location of Hrs when the 
interaction occurs. If activity does increase Hrs/KIF13A interaction, it would be interesting to 
assess how KIF13A is localized to Hrs+ vesicles, whether by fusion between these vesicles and 
others carrying KIF13A, or by a calcium-dependent recruitment of cytoplasmic KIF13A to these 
vesicles. To distinguish between these possibilities, axons of neurons co-transfected with 
KIF13A and Hrs should be imaged in the presence and absence of activity treatments to assess 
the localization of KIF13A relative to Hrs+ vesicles. It is also possible that KIF13A is always 
present on Hrs+ vesicles, but is activated, or recruits a necessary effector, in response to activity. 
This scenario would be supported if the described experiments do not show an increase in 
Hrs/KIF13A colocalization in response to neuronal activity. Mass spectrometry and proteomic 
analysis could be performed on purified Hrs+ and KIF13A+ vesicles to determine whether their 
composition changes with activity. Future experiments will also identify other motor proteins 
responsible for ESCRT-0 vesicle motility, including the dynein adaptors involved in retrograde 
transport of these vesicles. These can be initially identified using immunoprecipitation and split-
kinesin assays as described here. These studies are particularly important in light of the 
bidirectional transport profile of ESCRT-0 proteins (Figure 7F,M). As mentioned above, it is 
possible that the retrogradely-motile ESCRT-0 puncta we observe represent later stage 
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endosomes or amphisomes that have obtained their cargo and begun the journey back to the 
soma for lysosomal degradation. If this is the case, we may see that later ESCRT proteins (-I, -II, 
-III, VPS4) are also present on these retrogradely-moving structures. Overall, there is still much 
to learn about the roles and regulation of the ESCRT pathway in neurons. However, this work 




 The ESCRT pathway plays a vital role in maintaining neuronal health and is intimately 
linked to neurodegenerative disease. Here, we have illuminated a novel mechanism for 
spatiotemporal regulation of the ESCRT pathway in neurons, based on the activity-induced 
axonal transport of pro-degradative ESCRT-0 vesicles by kinesin motor protein KIF13A. These 
findings broaden our understanding of how protein degradation is regulated in neurons and shed 
light on how disruption of this degradative pathway may contribute to the etiology of 
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